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Hormones are key control molecules fundamental to most biochemical functions in the 
body. The endocrine system is responsible for the synthesis, regulation and secretion 
of sex hormones into the circulatory system to control target organs, tissue and cells 
through receptor mediated responses. The balance between two key steroid hormones, 
17b-estradiol (E2) and testosterone, the female and male sex hormones respectively is 
critical for fetal growth and development. A disruption to this tightly regulated system 
may lead to implications such as early onset of puberty in girls, decreased sperm count, 
and increased risk of breast cancer in postmenopausal women. Xenoestrogens (from 
the Greek xenos meaning stranger) are foreign compounds that have structural 
similarities to E2 and although the binding site for E2 is very specific, they have the 
ability to bind to estrogen receptors (ERs) but not as well, resulting in less of a 
biological response. Each xenoestrogen has a different affinity for ERs resulting in 
various cellular responses – also known as estrogenicity.  
 
There has been an increasing interest in the concentration of xenoestrogens in cow’s 
milk due to the possible effects consuming these compounds may have on the 
population. Here, this study utilised and evaluated a method for extracting endogenous 
estrogens (E2) and xenoestrogens (17a-ethinyl estradiol; EE2, formononetin, genistein, 
daidzein, equol, bisphenol A; BPA and zearalenone) from cow’s milk. The performance 
of this method was acceptable with recoveries ranging from 62% (BPA) to 95% (EE2), 
limits of determination ranging from 0.0025 mg/L (daidzein) to 0.1 mg/L (E2) and 
limits of quantification of similar values ranging from 0.05 mg/l (zearalenone) to 1 
mg/L (E2).  
 
During the duration of the current study articles were published citing tests that found 
trace amounts of the herbicide, glyphosate, in Ben and Jerry’s ice cream in the United 
Kingdom. These findings and published literature on glyphosates ability to induce 
human breast cancer cell growth lead to question the presence of glyphosate in New 
Zealand cow’s milk. A previously accepted extraction method was used to determine 
the presence of glyphosate, due to the low concentrations published, direct inject probe 
 xiv 
mass spectroscopy was utilised. In sampled New Zealand cow’s milk from the 
Canterbury region (n = 5), no mass ion consistent with glyphosate was identified. 
 
This extraction method was used to assess the safety of New Zealand cow’s milk in an 
estrogenic mimic context. In sampled New Zealand cow’s milk from the Canterbury 
region (n = 30), BPA was identified in 9 samples at concentrations ranging from 0.012 
mg/L to 0.066 mg/L, daidzein was identified in 1 sample at a concentration of 0.026 
mg/L and genistein was identified in 1 sample after treatment with sulfatase/b-
glucuronidase at a concentration of 0.062 mg/L. Based on the values from this study a 
person who drinks the New Zealand population’s average amount of milk (133 mL) 
would not be exposed to concentrations of each compound that exceeds their acceptable 
daily intakes (BPA, 0.05 mg/kg bw; genistein, 1.5 x 10-4 mg/kg bw; and daidzein no 
data (based on structural similarities to genistein it was assumed daidzein would have 
a similar acceptable daily intake value)). In New Zealand, cow’s milk is an essential 
part of the diet providing key minerals and nutrients, the findings in the present study 
suggest that New Zealand cow’s milk is safe. However, future studies could investigate 
whether more sensitive analytical techniques could detect other possible xenoestrogens 
at lower concentrations compared to high performance liquid chromatography – diode 
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Chapter 1 – Introduction 
 
1.1 Brief Overview 
 
The broad ranging biological importance of steroid hormones is well understood; for 
example, steroid hormones have key roles in metabolism, growth and development, and 
reproduction.1-6 Additionally, compounds have been shown to mimic one of the natural 
estrogens, 17β-estradiol (E2; Fig. 1.1), and bind to the estrogen receptors (ERs) 
estrogen receptor a (ERa) and estrogen receptor b (ERb). 7, 8 Binding to the ERs can 
elicit a range of responses which can, in turn, lead to adverse effects such as an 
increased risk of some cancers (e.g. breast and ovarian), and reproductive and 
developmental abnormalities.5, 9 It is possible that a large exposure to these estrogen 
mimicking compounds are via the human diet, particularly the dietary staples (e.g. milk, 
bread in New Zealand).5, 10, 11 Dietary staples are an important part of the human diet 
because they provide a major source of energy and contain nutrients and minerals that 
the body requires. Cow’s milk is a dietary staple and is consumed globally, likely due 
to the health benefits it exhibits (e.g. increased bone strength from calcium consumption 
via milk). However, previously reported studies in several countries (e.g. USA, China) 
show the presence of estrogen mimics in milk. 12-22 Despite this finding, only a limited 
range of studies have been conducted that explore the presence of endogenous estrogens 
and xenoestrogens in New Zealand cow’s milk. This is surprising because New Zealand 
is one the largest milk exporter in the world. 
1.2 Steroid Hormones and the Endocrine System  
 
Steroid hormones are important in control mechanisms for many biological functions, 
including, but not limited to, metabolism, inflammation, growth and development, 
immune function, and reproduction.1 The biosynthesis and release of steroid hormones 
is the responsibility of the endocrine system; once biosynthesised, they are secreted into 
the circulatory system and extracellular fluids to be carried to organs, tissues and cells.1, 
2 Once they reach their destination they modulate cellular activity through receptor-
mediated responses.1, 2 There are two classes of steroid hormones; sex steroids and 
corticosteroids (Fig. 1.1). Corticosteroids are produced in the adrenal cortex of 
 3 
vertebrates; for example, the biosynthesises of cortisol in response to stress. Whereas, 
sex steroids are produced by the gonads (ovaries or testes), adrenal glands, or through 
conversion of other sex steroids in other tissues (e.g. adipose tissue, liver).3, 4 Two 
examples of sex steroids are the major female hormone E2, and the major male 
hormone testosterone. The levels of steroid hormones are tightly regulated in the body 
by feedback mechanisms; in particular their production and degradation. These are 
highly controlled because of their narrow activity characteristics; for example, if E2 is 
present in excess, it will lead to the down regulation of enzymes responsible for the 
synthesis of E2.23 An important time that these hormones are tightly controlled is during 
the formation of the fetus’ sex characteristics (e.g. reproductive organs such as the testis 
and ovaries).5, 23 Development of these organs is reliant on the balance between the 
male and female hormones (testosterone and E2 respectively).5 If the balance of these 
hormones are upset, growth and development changes might result (e.g. 
adenocarcinoma, cryptorchidism).5 The actions of these hormones are receptor 
mediated; therefore these effects (e.g. adenocarcinoma, cryptorchidism) can occur by 
an increase of binding to a hormone receptor. These receptors can be either extracellular 
or intracellular.6 Extracellular or cell surface receptors are signal transducers; an 
extracellular signal, i.e. the hormone, binds and activates a receptor leading to a cellular 
response.6 Therefore, the feedback mechanism to control the synthesis of hormone is 
critical for normal growth and development.  
 4 
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Figure 1.1: The key sex steroids and corticosteroids.  
 
1.2.1 Biosynthesis of Steroid Hormones 
 
There are three specialised regions that synthesise steroid hormones in the endocrine 
system, namely the adrenal cortex, ovary, and testis. Release of hormones from these 
organs are controlled by specific extracellular hormones and activators initiating the 
intracellular processes, thus changing the steroid output.24 For example, the 
hypothalamus biosynthesises hormones which stimulate the anterior pituitary gland.25 
In turn, the anterior pituitary gland releases the thyroid stimulating hormone, which 
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concentration of T3 and T4 rise, they inhibit both the pituitary and hypothalamus in a 
negative feedback loop so controlling the thyroxine hormone levels and thus activity.25 
While T3 and T4 are not steroid hormones they are a useful example of the mechanism 
and importance of tight control. The steroid hormones are similarly regulated by a 
complex array of feedback mechanisms.   
 
The biosynthesis of the steroid hormones begins with the conversion of cholesterol to 
pregnenolone by cytochrome P450 side-chain cleavage enzyme (P450scc) located in 
the inner mitochondrial membrane of steroidogenic cells (Fig. 1.2).26, 27 Pregnenolone 
exits the mitochondrion and is transported to the endoplasmic reticulum where it is 
converted to progesterone by 3β-hydroxysteroid dehydrogenase (3β-HSD; Fig 1.2) – 
an important feedback controlled biosynthetic enzyme.26, 27 Some steroidogenic cells 
possess a mitochondrial form of 3β-HSD which converts pregnenolone to progesterone 
before it leaves the mitochondrion.27 However, in most species and steroidogenic 
tissues, the conversion of pregnenolone to progesterone is carried out in the microsomal 
compartment.27 In the microsomal compartment, progesterone is converted to an array 
of other steroids with the assistance of a contingent of enzymes in those tissues; for 
example, ovarian theca cells secrete androgens which are converted to E2 by ovarian 
granulosa cells.27 Likewise, testicular Leydig cells synthesise the androgen, 
testosterone.27 The final step in the biosynthesis of estrogens is the conversion of the 
androgens, namely testosterone and androstenedion, to E2 and E1 respectively (Fig. 
1.2).26 The enzyme responsible for this is aromatase (CYP19A1), a member of the 
cytochrome P450 superfamily.28 The distribution of this cytochrome P450 member is 
wide; located in the gonads, brain, placenta, and adipose tissue.28 The wide distribution 
of aromatase means that it might play an important role in the balance of the androgens 





























Figure 1.2: The first step in steroid hormone biosynthesis, converting cholesterol (A) 
to pregnenolone (B) catalysed by P450scc in the mitochondrion. Pregnenolone 
transported out of the mitochondria where it is converted to the androgens 
testosterone (C) and androstenedione (D) by a contingent of enzymes. These are 
finally converted to the estrogens E2 (E) and E1 (F) by the cytochrome P450 






























Three natural estrogens are produced in vertebrates; namely, estrone (E1; Fig. 1.3, B), 
E2 (Fig. 1.3, A), and estriol (E3; Fig. 1.3, C). E2 is the most biologically active natural 
estrogen. Of these estrogens, E1 was the first estrogen to be isolated by Adolf Butenandt 
and Edward Adelbert Doisy in 1929 followed by the discovery of E2 and E3.29  
Estrogens are responsible for the development of female secondary sex characteristics 
(e.g. breasts, wider hips, fat distribution), and for regulation of the menstrual cycle. In 
women, the major sites for the biosynthesis of estrogens in the ovaries and placenta; 
and to a lesser extent in the liver, adrenal cortex, fat cells and mammary glands.30 The 
biosynthesis of estrogens are increased during pregnancy; this increase is caused by the 
increased production of estrogens in the placenta.31  
 
Estrogens are also important in men; they modulate libido, spermatogenesis, and 
erectile function.30 The major site of production of estrogens in men is in the testis by 
the Leydig cells, but some is also produced in the brain.32, 33 The levels and roles of 
estrogens in the body vary depending on the sex, age, stage of fetus development, and 
pregnancy status of the individual.34 The levels of estrogens can be altered on purpose 
































1.3.1 Oral contraceptives  
 
In the 1960’s the oral contraceptive known as “The Pill” was approved for use in the 
United States of America (USA).7, 8 Oral contraceptives work achieve this thorough the 
prevention ovulation by the suppression of gonadotropin release.35 In these 
contraceptive, a synthetic estrogen is used, usually 17α-ethinylestradiol (EE2; Fig. 
1.4).7, 8 The structure is strikingly similar to that of E2, sharing the same backbone and 
similar functional group arrangements. EE2 is an antagonist of ERα and ERβ; which 
has 233% and 37.8% the binding affinity of E2 for ERα and ERβ respectively.36 EE2 
is the most suitable contraceptive because of the 17α-ethinyl group (Fig. 1.4, A; circled 
in red). This group prevents oxidation of the 17β hydroxyl by 17β-hydroxysteriod 
dehydrogenase, keeping it active for longer, thus mediating a higher relative estrogenic 
activity in the uterus.37 This means an egg is not released from the ovaries to be 
fertilised.37 However, EE2 undergoes rapid metabolism by effective first-pass 
metabolism which means that very little of the oral dose of EE2 is in circulation un-
metabolised.38 The metabolism of EE2 is typically through conjugation with the 
addition of a sulfate.38, 39 This generates the sulfated metabolite, EE2-3-O-sulfate  (Fig. 
1.4, C).38, 39 The other metabolism route of EE2 is through hydroxylation, with the main 
product being EE2-2-hydroxy (Fig. 1.4, B).38, 39 These metabolites are hormonally 
inactive and excreted via urine and faeces.40 Contraception is not the only use for 





























Figure 1.4: The metabolic deactivation of EE2 (A) by hydroxylation to produce 2-
hydroxy-EE2 (B) or by sulfation of the 17-hydroxyl to produce EE2-3-O-sulfate 
(C). The ethyl group is shown circled in red. 
 
1.3.2 Hormone Replacement Therapy 
 
Menopause is the time when menstrual periods stop permanently in women, meaning 
they no longer are able to bear children. Typically, this occurs between 42 and 59 years 
of age.41 Menopause is defined as the decreased production of hormones (e.g. E2) by 
the ovaries.42 The decline in E2 levels can lead to symptoms including hot flushes, 
tiredness, joint and bone pain, and headaches.41 These symptoms can cause significant 
disruption at a delicate time in a women’s life. These symptoms can be alleviated by 
the replacement of endogenous estrogens. Compounds such as synthetic mimics of 
estrogens (e.g. synthetically made E2, progesterone, or progestins, and sometimes, 
testosterone) are used to replace endogenous estrogens.9 The replacement of 
endogenous estrogens with synthetic mimics of endogenous estrogens is known as 





















to have some symptoms alleviated; for example, fewer bone fractures compared with 
postmenopausal women not using HRT due to an increased bone density.43, 44 Another 
benefit of using HRT is that it can decrease the risk of colon cancer in postmenopausal 
women.45, 46 In a study of over 56,000 postmenopausal women, a 17% decrease of colon 
cancer risk was observed compared with woman who did not use HRT.47 However, 
HRT is also associated with negative side effects such as an increased risk of coronary 
heart disease, stroke, thromboembolic events, and breast cancer with extended use.9 
The risks associated with using HRT to replace endogenous estrogens (e.g. E2) can put 
doubt in women’s minds at this delicate time in their lives because the risk appear large.  
 
1.3.3 17β-Estradiol  
 
E2 is the primary and most potent natural female steroid hormone in humans. E2 is 
biosynthesized enzymatically in many tissues through an enzymatic pathway. This 
pathway converts cholesterol to testosterone or E1 and finally to E2. There are many 
important roles of E2 in humans; for example, it is responsible for secondary sex 
characteristics (e.g. breast development), puberty onset, and the control of the 
menstrual and reproductive cycle in females. The level of E2 will depend on the age, 
sex, and stage of menstrual cycle of an individual.48-50 The serum E2 concentration in 
women will fluctuate with progression of the menstrual cycle (Fig. 1.5).48-50 During the 
follicular phase of the menstrual cycle, E2 increases, until ovulation is reached, peaking 
as high as 9 x 10-4 mg/L (Fig. 1.5).51 After the egg is released in the ovulation phase, 
E2 concentrations decrease and plateau; this is known as the luteal phase (Fig. 1.5).51 
However, E2 levels will fluctuate between the plateau range during this phase (Fig. 
1.5).51 The length of the follicular, ovulation, and luteal phase can vary depending on 
an individual.  
In males, the serum E2 concentration is lower than in women; however, E2 has an 
important role in sperm maturation and libido. The serum concentration of E2 in males 
pre-pubescent children, and post-menopausal women range from 5 x 10-6 to 4.6 x 10-5 
mg/L; whereas, a women’s serum E2 concentration ranges from 3.1 x 10-5 to 4 x 10-4 
mg/L.50 Even though the blood concentration of E2 has a large range depending on age, 
sex, and stage of menstrual cycle, concentrations will be higher than E1 and E3.48-50  
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Figure 1.5: Serum levels of circulating E2 in women during the menstrual cycle 
showing the large fluctuations throughout. Ovulation usually occurs on day 13 or 
14. Figure adapted from Shaw IC (2018) Food Safety - The Science of Keeping 
Food Safe, Wiley-Blackwell, p251, Fig. 9.7.  
 
1.3.4 Estriol  
 
E3 was first isolated in 1930 by Doisy and Marrian from the urine of pregnant women.52 
Soon after E3s discovery, the non-protein bound or ‘free’ concentration of E3 in the 
placenta was found to be much higher than E1 and E2 during pregnancy.53 However, 
the estrogenic activity of E3 is much lower than E2.54 During pregnancy, E3 is the most 
biosynthesised estrogen; with biosynthesis of E3 being increased in the placenta during 
this time.55 E3 is also present in high concentrations in human bile, meconium, and the 
corpus luteum.56 During the regular menstrual cycle of women, concentrations of E3 
are undetectable due to its rapid metabolism and clearance in urine.55  Unlike E1 and 
E2, E3 is not biosynthesised in the ovaries, instead it is biosynthesised in the liver. This 
is achieved through the hydroxylation of E1 and E2 by cytochrome P450 3A4 (Fig. 
1.6).55  
E3 is also used clinically in the treatment of problems associated with a lack of 
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E3 treatment works by mimicking the activity of E2 by binding to ERs; and by 
increasing the concentration of circulating estrogens. 
 
 





E1 was the first pure steroid hormone to be isolated by Adolf Butenandt in 1929 from 
the urine of pregnant women.29 Like other estrogens, E1 is biosynthesised from 
cholesterol in the gonads and adipose tissue. E1 can also be biosynthesised by the 
reversible conversion of E2 to E1.37 This conversion is catalysed by  the enzyme 17β-
hydroxysteroid dehydrogenase (Fig. 1.7) in the liver, uterus, and the mammary 
glands.37 Thus, when E2 is required to maintain homeostasis, the cell can carry out the 
conversion of E1 to E2 to increase the concentration of E2 in the body. This is the likely 
reason why E1 is used to clinically treat postmenopausal symptoms.  
E1 is used to alleviate postmenopausal symptoms such as hot flushes, which is achieved 
by being converted to E2 in the body, or by mimicking E2 activity through binding to 
ERs.37 However, E1 is no longer used in postmenopausal treatment. The reason for this 
is because synthetic estrogens with better properties, such as, longer activity, oral 
























Figure 1.7: The metabolic interconversion of E2 (A) and E1 (B) catalysed by the 17β-
hydroxysteroid dehydrogenase enzyme. 
 
1.3.6 Estrogen transport  
 
All steroid hormones are transported bound to carrier proteins in the bloodstream, 
which increases their water solubility and reduces their activity. A small proportion (1 
– 2%) of E2 is present unbound or ‘free’ from cattier proteins in the bloodstream.37 This 
‘free’ estrogen is biologically active and able to enter cells to bind to ERs. The 
remaining 98 – 99% of E2 is bound to one of three carrier proteins; serum albumin, 
corticosteroid-binding globulin, or sex-hormone binding globulin (SHBG; Fig. 1.8). 
Binding of estrogens to these carrier proteins renders them inactive, thus the 
bioavailability of estrogens is governed by the concentration of carrier proteins in the 
blood stream.57, 58 SHBG is the most important carrier protein because it has the highest 
affinity for sex hormones. SHBG has the ability to bind to a specific receptor for the 
carrier protein on plasma membranes of cells.57 A allosteric relationship exists between 
steroid binding and membrane binding.57 It has been suggested that SHBG receptors 
exist on sex hormone-dependent tissues (e.g. endometrium, breast) meaning this is a 
mechanism for controlling the action of sex steroids on their target tissues.59 
Biosynthesis of SHBG occurs primarily in the liver and released into the bloodstream.60 
The biosynthesis of SHBG is decreased in postmenopausal women likely because of 
the low blood concentration of estrogens, suggesting that SHBG biosynthesis is 
controlled by the circulating concentration of estrogens.59, 61 In postmenopausal 
women, data suggests that there is a correlation between a high risk of breast cancer 
and high free estrogen levels in combination with low levels of SHBG.59, 62 This hints 













the levels of SHBG are reversed because of the increased concentration of estrogens; 





















Figure 1.8: Crystal structure of E2 bound to the N-terminal domain of the carrier protein 
SHBG. Image produced in Schrödinger suite 2017 Maestro. PBD ID: 1LHU63 
 
1.4 Estrogen Receptors 
 
Binding of E2 to the ligand binding domain (LBD) facilitates activation, and ligand 
induced conformational changes of ERs (Fig. 1.9). This conformational change of the 
ERs exposes amino acids which facilitate dimerisation of ERs.64 A ER dimer can be a 
homodimer (i.e. ERα:ERα or ERβ:ERβ), or a heterodimer (i.e. ERα:ERβ). The 
hormone/receptor dimer complex (Fig. 1.9) is translocated into the nucleus where it 
binds to specific sections of DNA known as estrogen response elements (EREs), 
E2 Bound 
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activating transcription of the estrogen responsive genes (e.g. genes responsible for the 














Figure 1.9: Human ERα LBD in complex with E2. Image produced in Schrödinger suite 
2017 Maestro. PBD ID: 1ERE 66 
 
The two ER isoforms are encoded by individual genes located on chromosome 6 and 
14 (ERα and ERβ respectively). ERα was discovered by Elwood Jensen in 1962, and 
described as the estrogen binding protein.67 Isolation was not achieved until the 1980’s 
when Green et al. cloned the DNA encoding ERα present in the MCF-7 breast cancer 
cell line.68 A decade later, ERβ was discovered when ERα knockout rats were found to 
be viable but infertile.69 It was a surprise that ERα knockout rats were still healthy 
because of the known importance of E2 to the development of breasts and uterine; as 
well as the effects E2 has on the cardiovascular system and bone density.69 This finding 
suggested that there must be an alternative mechanism by which E2 could affect growth 
and development (e.g. another receptor).69 In subsequent studies, ERβ was 
characterised from a rat prostate cDNA library.70 The ability for E2 to bind to both 
receptors suggested that the receptors share a common ancestral receptor gene.71 
  
The ERs are evolutionary conserved, with structurally and functionally distinct 
domains, with the most conserved region being the DNA binding domain (DBD).70, 72 
This region is responsible for DNA recognition and binding to EREs, and shares more 
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than 95% amino acid homology between ERs.70, 72 All EREs contain the palindromic 
hexanucleotide (5’AGGTCAnnnTGACCT3’) region where ERs bind to DNA, which 
is the reason for the large similarity between ER’s DBDs.73, 74 The EREs have an 
important role in regulation of genes by determining the binding affinity of ERs and 
modulate the recruitment of co-activators.75, 76 A ligand bound to the ERs is required 
before the binding to EREs.   
Ligand binding occurs in the –COOH terminal multifunctional LBD.72 The LBD 
consists of 12 protein helices which are intimately related; therefore, if there is a 
conformational change of one helix, this leads to a conformational change of another. 
When an agonist binds to the LBD of ERs, the 12 helices form a three-layered 
antiparallel α-helical sandwich. The central core layer comprises H5/6, H9 and H10, 
with the outer layers comprising of H1 - 4 on one side and H7, H8, and H11 on the 
other side – which generates a ‘wedge shape’ structure.66 These series of 
conformational changes mediate the actions which are triggered by ligand binding (e.g. 
ER dimerisation). The LBD protein sequences of ERs has a 55% homology; however, 
there is high sequence homology between residues 223 – 343 and 404 – 457.70, 77 These 
highly conserved regions are the residues which are in direct contact with the ligand, 
which are highly protected by being buried within the protein structure. The slight 
differences between the ERs LBDs account for the differences in their affinities for 
E2.70 The first X-ray crystal structure of E2 bound to the LBD of ERα was published 
in 1997.66 This showed that the LBD comprises 11 α-helices (H1 – H11) and E2 buried 
in a highly hydrophobic cavity formed by 22 amino acid residues.66 The hydroxyl 
groups located at each end of E2 are critical for orientating the ligand in the ligand 
binding cavity (LBC). The hydroxyl groups of E2 form hydrogen bonds with Glu353 
of H3, Arg394 of H5, a water molecule, and His524 of H11 (Fig. 1.10).66 Other 
interactions have been suggested to be important for binding; for example, the 
hydrophobic interactions between the ligand’s backbone and the residues in the LBC 
which are critical for ligand binding and position of the energy necessary for the 
ensuring conformational changes.78  
The least conserved region of ERs is the N-terminal domain which varies in sequence 
and length between isoforms.70 Transcriptional activation is dependent on two 
activation function (AF) domains, AF-1 and AF-2. AF-1 is located at the N-terminus 
and is constitutively active.72 Whereas, AF-2 is located at the C terminal of the LBD 
and is ligand dependent.72 These AF domains recruit a variety of co-regulatory proteins 
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once ER dimers are bound to EREs. These proteins facilitate activation of the DNA 
bound receptor/ligand complex. The co-regulatory proteins that are recruited determine 
the activation of the complex. 
 
ERs are distributed in cells throughout the body; however, there are some differences 
between their isoforms. ERα has a broad expression pattern, distributed in breast cells, 
hypothalamus, endometrium, and ovarian stromal cells.79, 80 Whereas, ERβ has a more 
focused distribution with high levels found in the ovary, prostate, lung, brain, and 
endothelial cells.80, 81 It is possible for compounds which are present in these cells 














Figure 1.10: X-ray crystal structure of E2 bound to the LBD of the ER. The yellow 
dashed lines indicate hydrogen bonds. Image produced in Schrödinger suite 2017 




Xenoestrogens (from the Greek xenos meaning stranger) are foreign compounds that 
structurally mimic E2 and are capable of binding to ERs.64 Over 800 compounds have 
been identified as xenoestrogens in a recent World Health Organization (WHO) 






xenoestrogens are anthropogenic compounds which can contaminate the environment 
and food; for example, EE2 (from the contraceptive pill; Fig 1.4), bisphenol A (BPA; 
a polycarbonate plastic monomer; Fig. 1.11), and dichlorodiphenyltrichloroethane 
(DDT; an insecticide; Fig. 1.11). Natural xenoestrogens are compounds which are 
naturally produced for example, phytoestrogens produced by plants which are 
xenoestrogens to humans (e.g. genistein and daidzein from soy; Fig 1.11), and 
mycotoxins produced by fungi (e.g. zearalenone from mouldy crops stored in humid 
conditions; Fig 1.11). Xenoestrogens also include pharmaceuticals such as tamoxifen 
(Fig 1.11) and its metabolite, 4-hydroxytamoxifen (Fig.1.13), used in the treatment and 
prevention of breast cancer.83 The xenoestrogens are a concern are because their 
original purpose was not intended to mimic E2; for example, BPA was designed to be 
used in the production plastics and epoxy resins such as plastic bottles and sports 
equipment (e.g. mouth guards) to make them clear and tough. However, BPA has the 
ability to mimic E2 and cause an estrogenic response by binding to ERs.84 Over the last 
century xenoestrogens have been increasingly contaminating the environment due to 
agricultural runoff, industrial waste, and pharmaceutical use, but long before, plants 















Figure 1.11: Natural and synthetic xenoestrogens; BPA (A), a monomer of 
polycarbonate plastic; DDT (B) an insecticide; genistein (C) and daidzein (D) 
phytoestrogens from soy; and zearalenone (E) from mouldy crops caused by 
fungi contamination when stored in humid climates; and Tamoxifen (F) the 
pharmaceutical used in the treatment of breast cancer.   
 
1.5.1 Mechanism of Action of Xenoestrogens 
 
A characteristic of entering puberty is the increased production of hypothalamic 
gonadotropin releasing hormone. In turn, this releases two important hormones from 
the anterior pituitary gland, luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH). The response to this in females is for the ovaries to secrete E2, which encourages 
breast development, fat re-distribution, and skeletal development. Xenoestrogens are 
able to mimic E2, therefore it is possible that exposure to estrogen mimics before the 
natural release of E2 could interfere with the process of puberty mentioned previously. 
This could have effects in the growth and development of children and increase the risk 
of some cancers (e.g. mammary tumors).86 
There are two possible mechanisms of actions for xenoestrogens. They can either alter 
feedback loops in tissues (e.g. gonads, brain, thyroid etc.) by mimicking the estrogenic 
effects of binding to specific receptors; either activating (agonist) them or blocking 
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ERs), blocking the natural hormones (e.g. E2) from binding, therefore blocking the 
natural responses of binding to hormone receptors. Xenoestrogens can be either 
antagonists or agonists of hormone receptors. If the xenoestrogen is an agonist, it will 
bind and activate the receptor to produce a biological response (e.g. up regulation of 
the genes responsible for E2 production). However, if the xenoestrogen is an antagonist, 
it will block or dampen a biological response by binding and blocking the receptor and 
prevent or reduce E2’s binding. It is possible for a xenoestrogen to be an agonist in one 
tissue, and an antagonist in another.87  Most xenoestrogens are weak estrogens, which 
means that they are partial agonists and/or partial antagonist of ERs.87 Thus, the 
estrogenic effects is not completely the effect of the compound, rather, it depends on 
several factors including the cellular context (e.g. metabolism) and interactions with 
other signaling pathways.87  The complete mechanisms of xenoestrogens and how they 
cause a response are complex and not completely understood. 
 
Xenoestrogens are required to bind to ERs to initiate its mechanism of action.87 Thus 
the same or similar binding requirements that exist for endogenous estrogens binding 
to ERs must be met. The interactions required for binding to ERa are outlined in 
Section 1.3; briefly, binding to ERa requires two hydrogen bonds to be formed between 
the ligand and amino acid residues Glu353 of H3, Arg394 of H5, a water molecule, and 
His524 of H11 of the LBD. An example of a xenoestrogen capable of forming the 
necessary bonds to facilitate ER binding is genistein (Fig. 1.12). The binding affinity 
of a ligand depends on the strength of the bonds formed when ligands bind in the LBC, 
which leads to each xenoestrogen having a different binding affinity for ERs. The 
binding affinity of xenoestrogens for ERs will likely determine the response that is 
elicited by ERs. For example, if a compound has weak binding energies with ERa, it 
might have weak affinity for the receptor. However, if the compound does bind, the 
conformation change caused by the compound binding is likely to be different to E2; 
therefore, the response that is elicited is also likely to be different compared with a 
compound with strong binding energies (e.g. genistein vs. E2). Binding energy 
probably determines the magnitude of estrogenicity; a compound with large binding 
energies might cause a conformational change similar to E2, therefore it is likely to be 
more estrogenic and vice versa for a compound with weak binding energies. However, 
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Figure 1.12: Crystal structure of genistein bound to ERα. The yellow dashed lines 
indicate the hydrogen bonds formed between the ligand and the receptor. Image 
produced in Schrödinger suite 2017 Maestro. PBD ID:1X7R.88  
 
Strong binders of ER can be of helpful in a medicinal context; these compounds are 
employed in an array of treatment regimens (e.g. to decrease pregnancy complications, 
in breast cancer treatment) because they block the natural ligand and, therefore, its 
responses. Diethylstilbestrol (DES; Fig. 1.13, A) is an early example of a medicinal 
xenoestrogen designed to mimic E2. First synthesized by Leon Golberg in 1938, DES 
was used for the treatment of breast and prostate cancer, and soon after, prescribed to 
pregnant women to reduce pregnancy complications and losses.89, 90 However, in 1971 
the USA Food and Drug Administration (FDA) withdrew DES approvals because it 
was shown to cause a rare endometrial cancer in offspring following in-utero exposure. 
DES is a potent full agonist of both ERs, having 468% and 295% of the affinity of E2 
for ERα and ERβ respectively.77 This strong binding affinity, especially with ERα, is 
likely the reason for DES leading to endometrial cancers through the disruption of the 
proper expression of genes regulated by estrogens in the endoemertrium.91 In ERα 
knockout mice, complete resistance to chronic effects of neonatal DES exposure was 
observed compared to wild type mice.91, 92 However, in ERβ knock out male mice, the 
same neonatal DES exposure level effects as in wild type mice were observed.91, 92 This 
indicates that the agonistic binding of DES to ERα is responsible for the effects in the  






known, DES continued to be used for hormone treatment in advanced breast cancer. 
This was likely because of its strong binding to ERα, until tamoxifen was approved in 
1977. Tamoxifen is a prodrug and is metabolized by two isoforms of cytochrome p450 
(CYP2D6, CYP3A4) into the active metabolites 4-hydroxytamoxifen (Fig. 1.13, B), 
and N-desmethyl-4-hydroxytamoxifen. Both of these metabolites compete with E2 for 
the ERs active site.93, 94 These metabolites are ER antagonists, meaning that 
transcription of estrogen-responsive genes are inhibited, blocking estrogen effects and 












Figure 1.13: Two compounds used in the treatment of breast cancer; DES (A) and the 
active tamoxifen metabolite, 4-hydroxytamoxifen (B).  
 
1.5.2 Adverse Effects of Xenoestrogens 
 
For many years xenoestrogens have been associated with many adverse effects in both 
animals and humans (e.g. intersex fish, gonadal abnormalities in in male alligators).62, 
95-99 These effects are often observed in streams and rivers which are downstream to 
areas of conurbation (e.g. hospitals, wastewater sewage plants, and agricultural 
operation). The reason for this is that these areas discharge large amounts of 
xenoestrogens into rivers. This leads to the aquatic community being highly impacted 
by the compounds present in the discharge. A good example of this is the effect on fish 
at sites up stream versus downstream of a wastewater treatment plants (WWTP). 








in United Kingdom rivers receiving large quantities of WWTP effluent presented 
obvious changes.100 The changes observed were malformation of germ cells and/or 
reproductive ducts and altered gamete production, as well as intersex fish with an 
altered endocrine status and an elevated concentration of plasma vitellogenin.100 
Gonadal growth was only inhibited in severely intersex fish, whereas spermatogenesis 
was delayed in a large proportion of exposed intersex and male fish.100 In females living 
in effluent-contaminated rivers the effects were less obvious, although a higher 
incidence of ovarian follicle breakdown was identified compared to fish in non-effluent 
contaminated waters.100 The plasma E2 concentration of exposed intersex fish were 
between the concentrations found in control male and control female fish. Whereas, the 
plasma testosterone concentration was 2 to 3 fold higher in intersex than in male fish.100 
The cause of these changes were a result of exposure to hormonally active contaminants 
in the WWTP effluent.100 Vajda et al. showed similar effects as Jobling et al., but in 
white suckers (Catostomus commersoni) downstream of a WWTP.101 It was shown that 
gonadal intersex, sex ratio, gonad size, ovarian and testicular histopathology, and 
vitellogenin induction were affected in the white suckers downstream of WWTP.101 
The sex ratio was female dominated at the effluent site with the percentage being 79 - 
83% female.101 Upstream of the effluent site, there was no dominant sex, with the 
percentage of males being 36 - 46%.101 Of note, the percentage of intersex fish at the 
effluent site was 18 - 22%, whereas there was no intersex upstream of the effluent 
site.101 These effects are likely to be a consequence of the discharge of xenoestrogens 
into waterways. Effects of xenoestrogen consumption has also been hypothesised in 
humans.  
In 1992, Carlson and coworkers carried out a meta-analysis of sperm concentrations in 
men without the history of infertility from two databases.102 It was found that the mean 
sperm count had declined from 113 x 106/mL to 66 x 106/mL from 1940 to 1990.102 
Testicular cancer, cryptorchidism, and hypospadias were also linked decreased sperm 
counts.102 It was speculated that the source of these effects were caused by the exposure 
to estrogen mimics in the environment rather than genetic factors.102 Since this study, 
it is still speculated that estrogen mimics have the ability to effect sperm concentration 
and quality.95, 102-105 In 2016, a meta-analysis of published phytoestrogen consumption 
data from the USA and China were compared with their sperm concentrations over a 
similar time period.95 The study identified that China’s phytoestrogen consumption has 
declined by 67% from 1991 to 2008, whereas phytoestrogen consumption in the USA 
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increased by 1613% from 1993 to 2005.95 These changes in the consumption of 
phytoestrogens are likely because of the westernisation of the Chinese diet being 
‘trendy’, and the introduction of soy products into the USA.95 Interestingly, the Chinese 
sperm concentration increased by 34% from 1999 to 2008, whereas the concentration 
in the USA declined by 54% from 1938 to 2007 (Fig. 1.14).95 This suggests a link 
between phytoestrogen consumption and sperm concentration; a higher phytoestrogen 
diet might lead to a lower sperm concentration. Xenoestrogens effect the sperm 
concentrations by having negative effects on feedback loops on the secretion of FSH 
and LH, affecting the hypothalamo-pituitary system.103 FSH regulates Sertoli cell 
replication, this, in turn, coordinates and regulates spermatogenesis.103 Changes in the 
quantity and quality of Sertoli cells can occur before and after birth, especially in the 
pre-pubertal stage which likely affects sperm concentrations in older life.106 In animals, 
it has been shown that the alterations in Sertoli cell numbers during early life determines 
the size of the testicles and sperm output in adulthood.107 The  effects of xenoestrogens 
are not only limited to developmental problems (e.g. intersex fish, decreased 
concentration of sperm), it is thought that xenoestrogens can increase the risk of some 
cancers (e.g. breast cancer) 
 
 
Figure 1.14: Published sperm concentrations for the USA (1938 – 2007) and China 




























Breast cancer is the most common cancer in New Zealand women; 3000 people are 
diagnosed a year, with 600 deaths a year from the disease.108 Worldwide, breast cancer 
accounts for 25% of all cancers in women.109 Of all breast cancers, 83% are ER+, 
meaning the cancer cells express ERa and grow in response to E2.110 This means that 
women who are being exposed to xenoestrogens might have a higher risk of promoting 
the disease. This might be because of the effects xenoestrogens have on the endocrine 
system, acting like estrogens or altering the ‘normal’ metabolism of endogenous 
estrogens and instead act as carcinogens.111 The first example of xenoestrogens being 
able to cause proliferation of breast cancer cells was in 1991.112 It was demonstrated 
that proliferation of MCF-7 cells could occur in the absence of estrogens when the 
media used for culturing was stored in polystyrene centrifuge tubes.112 If the media was 
stored in glass centrifuge tubes, E2 supplementation was required for proliferation of 
these cells.112 These polystyrene tubes had been modified to make them more resistant 
to breakage; the compound responsible for the hardening of the plastic tubes, and the 
proliferation of MCF-7 cells was nonylphenol (NP; Fig. 1.15, A).112 Following this 
discover, research on NP continued and more compounds were identified to cause 
proliferation of MCF-7 cells.113-116 Soon after these findings, it was shown that the same 
effect occurs in animals; mice exposed to NP were shown to have a greater risk of breast 
cancer compared with mice exposed to E2 at the same concentration of NP.11 The 
reason for the increased risk is due to NP mimics the actions of E2 through binding to 
the ERs.11 117 NP also binds to cell surface ERs, mimicking the signal responses usually 
controlled by E2.117 Mice treated with NP had an increased production of E3 in the liver 
which was believed to be a reason for the increased risk of breast and mammary 
cancer.118 However, the primary purpose of xenoestrogens are for a specific purpose 
and are very useful. For example, BPA is used in the synthesis of polycarbonate plastics 
and epoxy resins, giving them qualities, such as being clear and tough. Plastics 
containing BPA are commonly used in bottles, food containers, glasses, teeth fillings, 
and thermal paper. The benefit that BPA has to offer in the protection of food from 
contamination is likely to far outweigh the risk of BPA leaching into the food as a 




1.5.3 Exposure to Xenoestrogens  
 
Data on human consumption of xenoestrogens is limited, however, there have been 
efforts made to estimate the consumption of xenoestrogens.64 The consumption of 
xenoestrogens can be assumed based on pesticide usage because they are likely linked. 
With the population continuing to grow, there is pressure on agriculture to increase 
production and become more efficient. This leads to the amount of pesticides used to 
increase because of the continual growth of the population. In developed countries, 
pesticide usage is monitored, and the pesticides are modified and adapted to be more 
targeted to the pest, break down faster in the environment, and be less of a risk to 
humans. This development means that less pesticide is required to be used and is broken 
down faster, therefore there is less burden on the environment. However, these 
developments come at a cost; in less developed countries, these modified pesticides are 
likely to be too expensive. This means that the less developed pesticides will be used 
which might have been shown to cause adverse effects to humans; for example DDT 
and the increase breast cancer risk.119-125 This could explain the link between the 
amount of pesticides being used, and the incidence of ER+ breast cancers, suggesting 
that xenoestrogens could be the cause of this link.126-128 An example of this possible 
link was shown in wives’ of husbands’ who sprayed pesticides on fields. These women 
had an increased risk of breast cancer compared with other women in the cohort study; 
a hypothesis for the reason this could be happening was because these women in closer  
proximity to the farms.128 This also could explain the observation that breast cancer 
occurrence is higher in lesser-developed countries where estrogenic pesticide usage is 








Figure 1.15: Two xenoestrogens known to increase the risk of breast cancer; NP (A), 





However, phytoestrogens (human xenoestrogens that are produced by plants), are used 
as an “over the counter” alternative to regular HRT to minimise menopausal symptoms. 
These symptoms are experienced by 80% of women in menopause, significantly 
reducing their quality of life.129 Extended use of prescription HRT used in menopausal 
women is associated with increased risk of heart disease, stroke, thromboembolic 
events, and breast cancer.9 Whereas phytoestrogen alternatives to HRT do not have 
these risks associated with them. The phytoestrogens (i.e. formononetin, daidzein, and 
genistein) of particular interest are those derived from soy, and plants of the Trifolium 
(clover) genus; for example, the major components of soy and clover, formononetin, 
daidzein, and genistein, all have good structural analogies with E2 (Fig. 1.16). In 1998, 
it was shown that high intake of soy was protective against breast cancer in pre- and 
post- menopausal women.130, 131 Phytoestrogen mixes have also been shown to reduce 
postmenopausal symptoms such as hot flushes and night sweats without the negative 
effects of HRT (e.g. increased risk of heart disease, stroke, ER rich tissue cancers).131, 
132 Phytoestrogens preferentially bind to ERβ, which may explain the decreased risk of 
some cancers where ERβ is the primary estrogen receptor (e.g. prostate).77, 80 Thus, 
phytoestrogens offer beneficial effects without being associated with the side effects 
linked to regular prescription HRT.77 However, it should be considered that genistein, 
the most prominent phytoestrogen in soy (Glycine max) and red clover (Trifolium 
pretense), enhances proliferation of MCF-7 cells at exposure concentrations as low as 
10 nM. Interestingly, genistein can illicit the same effects as E2 in MCF-7 cells at ten 
times the concentration.114 Exposure routes to genistein and other phytoestrogens are 

























Figure 1.16: The structural similarities can be seen between formononetin (top), 
daidzein (middle), genistein (bottom), with E2 (dark grey overlay) when 
superimposed (right respectively). Image produced in Schrödinger suite 2017 
Maestro. 
 
1.5.4 Routes of Exposure to Xenoestrogens  
 
Xenoestrogens are present in all areas of daily life; for example, the environment (in its 
broadest context, including the work place) food and its storage containers, and 
medicines (Fig. 1.17). The two main categories of xenoestrogens are natural and 
synthetic. Naturally produced xenoestrogens (e.g. genistein, daidzein) are produced by 
an organism to possibly allow for the survival of an organism (e.g. defense mechanisms, 
growth, and signaling). These compounds are not xenoestrogens to organisms 
producing them and cannot be controlled in food because they naturally occur. 
Whereas, synthetic xenoestrogens are compounds which were not intended to be 
estrogenic, unless designed as a pharmaceutical as an estrogen mimic (e.g. for industrial 
purposes, kill a pest to stop crop ruin, relive pain, or treat a medical condition). As 
discussed previously, in the case of BPA, the benefits offered by synthetic 
xenoestrogens are likely to far outweigh the risk of their consumption. Therefore, the 




























































































Natural xenoestrogens are compounds which are not produced by the endocrine system 
(e.g. genistein to humans). The most common exposure route to natural xenoestrogens 
is via the diet in the form of phytoestrogens.133 Typical dietary exposures to 
phytoestrogens are, but not limited to, soy-based formula, tofu, soy milk, and oats. In 
New Zealand, products requiring flour (e.g. bread, baked goods, cereal) or products 
requiring soy lecithin to be made, contain soy. Soy is known to contain phytoestrogens; 
in particular genistein, daidzein.133 Therefore, humans have the greatest exposure to 
genistein and daidzein from the diet. These compounds are not the only phytoestrogens 
in the diet; lignans and coumestrol are also present. Flaxseed (Linum usitatissimum) 
contains the precursors to lignans which are formed by bacterial fermentation in gut, 
generating estrogen mimics; for example the bacterial conversion of 
secoisolariciresinol (found in flaxseed) to enterodiol which bacteria further convert to 
the estrogen mimic enterolactone (Fig. 1.18).134 Whereas, coumestrol is an estrogen 
mimic without metabolism. These are commonly found at high concentrations in pinto 
beans, soybeans, and black chickpeas (kala chana).135 Phytoestrogens are not the only 

















Figure 1.18: The bacterial fermentation in the gut of secoisolariciresinol (A) to 
enterodiol (B) and finally converted by the gut microbiota to the lignan, 
enterolactone (C). 
 
Another group of natural xenoestrogens is the mycotoxins. These are toxic substances 
which are produced by fungus; for example, zearalenone produced by Fusarium fungi. 
Zearalenone is biosynthesized through a polyketide pathway of Fusarium fungi. The 
fungi in the genus which are capable pf producing zearalenone are F. graminearum, F. 
crookwellense, F. culmorum; which are a commonly found in temperate and warm 
countries.136 Cereal crops can be grown in these contaminated soils; therefore, these 
cereals are often contaminated with zearalenone.136 Mammals who graze these crops or 
eat these cereals containing zearalenone residues can metabolise it into two 
stereoisomers (α and β).137 This is achieved by reducing the C-8 keto group (Fig. 1.19) 
by the gut microbiota.137 These metabolites can also be produced by Fusarium fungi, 
but at much lower concentrations than zearalenone.137 The Fusarium fungi grow on and 
contaminate corn and to a lesser extent oats, wheat, millet, rice, barley, and sorghum 
and produce zearalenone and its metabolites.136 Contamination of these crops can also 
occur after harvesting, due to poor crop management; for example, high moisture 


















growth of fungi capable of producing zearalenone because they thrive in these 
conditions.136  
Endogenous estrogens are also present in the diet, particularly in meat and dairy 
products.138 These products are produced by animals which naturally produce 
endogenous estrogens; therefore these compounds will be present in their meat and 
milk. When a cow becomes pregnant or be injected with bovine somatotropin (bST), 
their endogenous estrogen production increases. These are likely to be transferred 
across the blood-milk barrier because they are important for the development of the 
calf. Compounds that mimic endogenous estrogens might also be able to cross the 








Figure 1.19: Metabolism in mammals of zearalenone by reducing the C-8 keto group 




DDT is a known endocrine disruptor and is highly restricted because of this; however, 
DDT metabolites are some of the most frequently found xenoestrogens in the 
environment. DDT was one of the first wide spread pesticides, however, today we still 
live with the long-lasting effects. In 2002, DDT and its metabolites were shown to be 
present in most food groups in the USA; including, baked goods, fruit, meat, poultry, 
and dairy products.139 DDT was banned for agricultural use in the USA in 1972 when 
it became apparent that DDT was accumulating in the environment, and biomagnifying 
in organisms. Biomagnification is where the concentration of a compound will increase 
through the trophic levels until it reaches the top of the food chain. This is where the 
highest concentration is received (e.g. humans eating a cow that eat grass with DDT 













aqueous stability meaning they persist in the environment.140 There are very slowly 
metabolised by microbial degradation, adding to their environmental persistence.140 
Another group of highly persistent estrogen mimics are the polychlorinated biphenyls 
(PCBs). PCB’s are used as coolants and insulating fluids, lubricants, plasticisers in 
paint and cements, polyvinyl chloride coatings, flame retardants, and adhesives which 
can be released into the environment. Similar to DDT, PCBs are broken down very 
slowly by biological transformation meaning they accumulate in the food chain.139 
Thus, they are biomagnified; the properties of PCBs allow their persistence in 
biological matrices such as human blood, adipose tissue, and milk promoting the 
biomagnification.139 Although these compounds were highly used in the past, the 
burden on the environment is still present, but is decreasing with time. Synthetic 
estrogens (e.g. EE2) are also commonly found in the environment from industrial 
effluent and consumer waste. However, they are not as persistent in the environment as 
DDT and PCBs. The reason for this is likely because they are readily degraded by 
microbes, plants, light, etc.141  
 
The synthetic plasticizer, BPA is commonly used in industry as a monomer in the 
production of polycarbonate plastics and epoxy resins; used in water bottles, baby’s 
bottle, and the lining of tin cans. It is well documented that BPA can leach from these 
products into the water and food stored in these containers. Therefore, the potential 
human exposure to BPA is high.142, 143  It is unlikely that BPA accumulates in animals 
because it is rapidly metabolised by glucuronidation followed by excretion via urine.144 
 
Other environmental and waterway contaminants include alkylphenolic surfactants; for 
example, NP and octyphenol. These compounds are used in detergents, fuel and 
lubricants, polymers, fragrances, antioxidants, oil field chemicals, and fire-retardant 
materials.145 NP and octyphenol are known to affect aquatic species downstream from 
WWTP discharge and agricultural run-off sites.101 Drinking water has also been found 
to contain alkylpehenols which is concerning because of  endocrine disrupting 
ability.146These compounds are broken down through biological breakdown (i.e. 
bacteria, fungi) which produce short chain alkylphenols. However, these short chain 
alkylphenols are persistent due to their poor anaerobic degradation. Under aerobic 
conditions in the absence of bacteria and fungi, NP is biodegraded into an alcohol and 
hydroquinone which are not persistent.145 There is the possibility that these compounds 
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have the ability to bioaccumulate; however, in rats only doses that exceed  the animals 
detoxification abilities lead to bioaccumulation.147  
 
Exposure to these compounds can also come from occupational or clinical exposures. 
For example, people working in the production of contraceptives and synthetic 
hormones, or in the production of plastic containers. It is possible that the estrogenic 
compounds (e.g. EE2, synthetic estrogens, BPA) are absorbed across the skin. This 
commonly occurs farming; before DDT was restricted, crop dusters would receive huge 
doses from inhalation and absorption through their skin.148 People working in these 
industries are likely to be getting the highest does of xenoestrogens in the population. 
Exposure to xenoestrogens are broad and not limited to humans, animals are also likely 
exposed. It is possible that the xenoestrogens that animals are exposed to are passed 
onto humans through the consumption of their products. Therefore, it is possible that 
human exposure to xenoestrogens and endogenous estrogens from the diet are the cause 
of decreasing sperm count, increased incidence of ER+ breast cancer, and earlier age 
of menarche.  
 
1.6 Milk    
 
Milk is a staple of the western diet, routinely drunk in households in such quantities 
that it provides a large proportion of the diet. This means that it provides a large source 
of energy, minerals, vitamins, fats, and 15 other essential nutrients that the body 
requires.149 A benefit of milk it that it offers these in an easily digestible and accessible 
form.149 The New Zealand population consumption of cow’s milk has been consistent 
over the past decade (Fig. 1.20).150 In 2013, the New Zealand consumption of cow’s 
milk per capita was 133 mL per day (Fig. 1.20).150 Interestingly, China’s milk 
consumption has increased by almost 600% over the past three decades, showing the 
western influence on its diet (Fig. 1.20).150 A possible reason for this increase is that 
the western diet has become ‘trendy’ to consume in China; therefore, increasing the 
demand of popular western products, such as milk. In New Zealand, milk consumption 
is encouraged from a young age by schools. Fonterra (the largest dairy co-operative in 
the world) offers free milk to be given out at primary schools to encourage children to 
drink milk. Currently, 70% of primary schools in New Zealand have signed up to this 
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program. Milk consumption in children is import because of the association milk has 
with better bone and heart health, cancer protection, and decreasing osteoarthritis 
symptoms due to the calcium and vitamins A and D in milk. However, as mentioned 
previously, cow’s milk is likely to contain endogenous estrogens and xenoestrogens. 
The reason for this is that cows produce milk pre and post parturition, graze on pasture 
which might have been sprayed with pesticides and they consume soy-based silage 
which may have been poorly stored. Xenoestrogens have been shown to cross the 
blood-milk barrier by passive and active transport; therefore, xenoestrogens from 
pasture might be present in cow’s milk.12 It is possible that xenoestrogens could also 
migrate into milk from the polycarbonate containers and epoxy liners.151 The equipment 
used during the production process may also be lined with epoxy resins, or made from 
plastics containing BPA. Thus, it is possible that milk could contain an array of 
endogenous estrogens and xenoestrogens; therefore, humans who drink cow’s milk 
might receive a dose of these.  
 
  





















































































1.6.1 Routes of Milk Contamination by Xenoestrogens 
 
From the cow 
 
Better understanding and technological developments in agriculture have allowed 
farmers to breed cows which produce higher quantities of milk. Dairy cows must 
produce one calf a year or be injected with bST and suckled to continue to produce 
milk. When cows start produce milk, lactation is maintained by constant milking so that 
milk is continuously produced throughout lactation. Over the last 40 years, the amount 
of milk a dairy cow can produce has doubled, with the average cow producing more 
than 26 L/day of milk. 80% of the milk produced is from pregnant cows lactating, thus, 
the concentration of endogenous estrogens can be high.152 For example, estrone 
sulphate (E1S) concentrations can be extremely high in milk from modern cows, with  
concentrations ranging from 7.9 x 10-6 mg/L to 1.26 x 10-3 mg/L depending on the 
cow’s stage of pregnancy. E1S is a metabolite of E1 and is biologically inactive. 
However, E1S has a high bioactivity when consumed orally by humans and can be 
converted to E1 and E2 in the gut.103, 153, 154 Therefore, by consuming E1S, it can 
increase the concentration of active estrogens in the body. The total (free and 
conjugated) concentration of E2 in cow’s milk is much lower, ranging from                  
1.86 x 10-5 mg/L to 5.24 x 10-5 mg/L depending on the cow’s stage of pregnancy.12 
Although the concentration of E2 is much lower than E1S, but its biological activity is 
higher than E1S. However, the concentration of endogenous estrogens is likely to be 
lower than xenoestrogens because of the tight regulations set by regulators. 
 
Farming sources – food and farmer  
 
A cow’s food (e.g. grass, silage) and water is likely to be their major exposure route to 
xenoestrogens. In New Zealand, a dairy cow’s primary source of food is pasture 
(grassland) in paddocks which they graze. This pasture includes red clover (Trifolium 
pratense) and white clover (Trifolium repens); both are perennial legumes which are 
high in protein and fibre. Red clover is short lived and is usually sown in summer in 
dry areas where grazing is less intense. It does not persist well in high intensive 
agriculture areas. Whereas, white clover is the opposite; it is grown throughout New 
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Zealand, persisting well on moderate to high fertility soils, but does not persist well in 
dry summers. It maintains a high feed quality towards the end of spring when grass 
plants its seeds. This maintains the milk solid production of dairy cows high. The 
overall balance of red and white clover depends on the conditions they are in (e.g. time 
of year, if grazed). Both red and white clover have been shown to contain several 
phytoestrogens; namely, formononetin, biochanin A, genistein and daidzein.155-157 
These compounds are more concentrated in red clover silage (RCS) compared with 
white clover silage (WCS), which means that RCS is more estrogenic.155 RCS was 
shown to be more estrogenic by feeding cows only RCS or WCS and comparing the 
estrogenic load of the milk.155 The milk from cows fed a RCS had a higher 
phytoestrogen content than cows fed WCS.155, 156 However, it is possible that 
formononetin, biochanin A, genistein and daidzein can be metabolised in the cow’s 
rumen by gut microbiota. This results in changed functionality (e.g. the addition of 
hydroxyl groups, removal of a methyl group) and therefore, a change in their 
estrogenicity.155, 157-160 Of note, formononetin can be metabolised to daidzein, which is 
further metabolized to equol (Fig.1.21).155, 157-160 This is interesting because equol is 
more estrogenic than formononetin and daidzein.158 Thus, it is possible that eqoul is in 
low concentrations in clover; but after metabolism of formononetin and daidzein by the 
microbiota in the cow’s rumen, the concentration of equol might be higher in milk. 
Therefore, the estrogenicity of milk would increase. This is important because the 
metabolites of compounds can be more important in an estrogen mimic context than 
the parent compounds due to the increased functionality added due to metabolism. It is 
possible that not all phytoestrogen metabolites have been identified. These metabolites 
could have a higher estrogenicity than their parent compounds. Therefore, if these are 













Figure 1.21: Bacterial matablolism of formononetin (A) to equol (C) via daidzein (B) 
carried out in the rumen of cows. 
 
It is important that pasture quality is maintained to achieve high milk yields in dairy 
cows. There is pressure on farmer to achieve higher milk yields from cows because the 
human population is growing. Thus, farmers will protect their pasture which cows graze 
to maintain the efficiency of their farm. The pressure on farmers to increase production 
from farms led to the Green Revolution in the 1960s. This aimed to increase agricultural 
production worldwide by adopting new technologies.161 The increased efficiency was 
achieved by planting hybrid crops with increased production, greater acreage, 
mechanisation, and controlling pests (e.g. insecticides and herbicides).162 Insecticides 
and herbicides were adopted because they control pests, weeds, diseases (human, 
animal, and plant), and increase food production.163 However, most first generational 
pesticides were harmful to the environment, with some persisting in soils, aquatic 
environments, and bio-accumulating in the tissues of animals. The first widely used 
organic pesticide was DDT; which, led to the development of organophosphates, 
carbamates, and more organochlorides. Interestingly, one of the first pesticides to be 
highly restricted was DDT because of the recognition of the hazard DDT had to birds 
(e.g. increased deaths) and likely to be hazardous to humans (carcinogenicity) with 
extensive usage.161, 164 In 2008, a published risk assessment identified 127 pesticides 
from literature with known endocrine disrupting properties to humans.165 The most 
common of these pesticides were insecticides, followed by fungicides and 















their negative effects on the environment; however, these compounds still persist in the 




The most commonly used herbicide worldwide, glyphosate, is produced by the 
agrochemical giant, Monsanto. The most common glyphosate-based pesticide is sold 
under the tradename Roundup. Farmers in New Zealand used Roundup at the end of 
each season to kill off pasture before new pasture is planted; however, in other 
countries, such as the USA, farmers use Roundup because 75% of crops have been 
genetically modified for Roundup. These plants are able withstand high concentrations 
of glyphosate in their cells without dying, while the weeds die from these high 
concentrations.166 The genetically modified crops can withstand high concentrations of 
glyphosate because they are transfected with a resistant version of the gene for the 
enzyme targeted by glyphosate, enolpyruvylshikimate-3-phosphate synthase 
(EPSPS).167 Glyphosate is absorbed through the plant’s roots and transported to 
growing parts of the plant. Glyphosate kills weeds by inhibiting EPSPS, which catalyes 
the reaction between shikimate-3-phosphate (S3P) and phosphoenolpyruvate (PEP) to 
form 5-enolpyruvylshikimate-3-phosphate (EPS3P) through a tetrahedral reaction 
intermediate (Fig. 1.22).168 This is a key process in the shikimate pathway, critical for 
the synthesis of aromatic amino acids (i.e. phenylalanine, tyrosine, and tryptophan), 
folic acid, lignin, plastoquinones, auxins, phytoalexin, and many other secondary 
products.168, 169 Also, over 30% of the plants carbon fixation runs through this 
pathway.169 Inhibiting EPSPS with glyphosate leads to deregulated of this pathway, 
which causes more carbon to be direct through the pathway and the accumulation of 
shikimate and S3P, diverting energy sources to other areas.168, 169 Inhibition of EPSPS 
by glyphosate is achieved by glyphosate occupying the binding site designated for PEP, 
adjacent to S3P, mimicking an intermediate state of the ternary enzyme-substrate 
complex. This causes the enzyme to be inhibited because of the increased stability of 






















Figure 1.22: The enzymatic conversion of S3P (A) and PEP (B) to EPS3P (D) and 
phosphate (E) through a tetrahedral intermediate (C) catalysed by EPSPS. This 
enzyme is targeted by glyphosate (F), mimicking PEP (B) and binding to its 
designated site on EPSPS.   
 
Glyphosate-based herbicides are known pollutants of rivers and surface waters, as well 
as contaminants of food.166 It has been shown that shown that these herbicides are toxic 
to many organisms including human cell lines.166 Glyphosate is well adsorbed on soils 
and readily degraded by microbes to aminomethylphosphonic acid (AMPA), which is 
also strongly adsorbed to soils.171 However, surface waters are likely contaminated by 
glyphosate in soil runoff, which is not well broken down by water or sunlight.171 The 
half-life of glyphosate is about 47 days in soil, but the soil type and climate can affect 
its persistence. Whereas, the half-life in water can be up to 97 days. For this reason, 
pesticides have a withdrawal period, which is the time that products (e.g. pasture) must 
be left between being exposed to herbicides/pesticides and used or sold. Therefore, it is 
extremely important that the withdrawal periods set for glyphosate are abided by, 
especially if the fields are used for grazing and the waters drunk by cattle. If the 




























































The toxicity of glyphosate and glyphosate-based herbicides in-vivo is still in question 
likely because the toxicity profile it not understood. A known toxic component of 
glyphosate based herbicides are the surfactants.172, 173 These are an important part of 
these herbicides because they enable  glyphosate penetration of the plant’s cuticle. 172, 
173 Glyphosate was classified as “probably carcinogenic to humans” (category 2A) by 
the WHO International Agency for Research on Cancer in March, 20015.174, 175 This 
classification was based on epidemiological, animal and in vitro studies of 
glyphosate.174, 175 However, in 2016, a joint meeting between the United Nations Panel 
of Experts on Pesticide Residues in Food and the Environment and the WHO Core 
Assessment Group on Pesticide Residues reported that glyphosate was “not associated 
with genotoxic effects in an overwhelming majority of studies” up to 2000 mg/kg.176 
They declared that glyphosate was “unlikely to be genotoxic at anticipated dietary 
exposures.”176 This report also stated that glyphosate is unlikely to be carcinogenic in 
rodents, and it is “unlikely to pose a carcinogenic risk to humans” from dietary 
exposure.176 However, studies have shown that glyphosate-based herbicides can cause 
reproductive effects in-vivo (e.g. pregnancy problems, and sperm problems).166, 177-181 
Other effects such as cellular mutagenesis and toxicity have also been shown in cells 
involved in reproduction (e.g. placental, embryotic and fetal).166, 182-186 Glyphosate has 
also been shown to inhibit aromatase (CYP19A1) activity; the enzyme responsible for 
the conversion of androgens to estrogens (Fig. 1.2).166 The inhibition of aromatase has 
been shown to cause intersex gonads and female reproductive issues in amphibians; 
therefore the same effect could occur in humans.187 Glyphosate has also been shown to 
be estrogenic in MCF-7 cells by the proliferation of these cell; these cells grown in 
response to binding to the ERs.166, 188  When MCF-7 cells were exposed to glyphosate 
residues, they proliferated in a dose dependent manner.166, 188 Binding to ERs was 
confirmed with the addition of ICI 182, 780 (a potent antagonist of ERs), which blocked 
the proliferative effects by exposure to glyphosate.166, 188 This suggests that glyphosate 
is binding to ERs leading to proliferation of MCF-7 cells.166, 188 The exposure which 
caused the half maximal response (IC50) for glyphosate was similar to other 
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xenoestrogen agonists.166 Based on the data from human cell lines and animal models, 
glyphosate might be carcinogenic, mutagenic and reprotoxic at low exposures.166 Thus, 
it is possible that glyphosate is a health risk to humans. This contradicts the comments 
made by the joint meeting between the United Nations Panel of Experts on Pesticide 
Residues in Food and the Environment and the WHO Core Assessment Group on 
Pesticide Residues on glyphosate. This meeting commented that glyphosate was not 
associated with genotoxic effects and unlikely to pose a carcinogenic risk to humans 
because of the limited studies showing these effects at high concentrations. A possible 
explanation for the limited studies showing these effects is that glyphosate could be a 
is a non-genotoxic carcinogen. Therefore, inducing cancer through indirect stimulation 
of hyperplastic responses, without altering DNA, chromosome number and structure.189 
Non-genotoxic carcinogens have been shown to alter/induce, but are not limited to, 
endocrine modification (both receptor mediated and non-receptor mediated), immune 
suppression, tumor promotion, immune suppression, and tissue specific toxicity and 
inflammatory responses.189, 190 Non-genotoxic carcinogens have broad modes of action, 
which are, mostly, tissue and species specific.189 This could explain the mixed results 
of glyphosate toxicity in animals models. Non-genotoxic carcinogens are typically 
negative in tests for carcinogenicity.189 These tests are usually based on genotoxic 
endpoints; for example, the AMES test in bacteria, genotoxicity in mammalian cells 




Glyphosate is used in large quantities in agriculture which could contaminate food 
products (e.g. cereals). The first food glyphosate was identified in was ice cream from 
the United Kingdom in 2017.117 The concentrations that were present were extremely 
low (0.001 mg/L – 0.00123 mg/L); however, it is possible that these exposures could 
cause an effect to humans (e.g. reproduction effects, increase the risk of hormone 
related cancers).166, 177-186 The concentrations recorded in ice cream are 100-fold lower 
that the maximum residue limit (MRL) in food other than fruit.191 This might be 
concerning because the toxicity profile glyphosate is not well understood. It is possible 
that the low exposures could cause hormonal effects; for this reason, a lot of 
controversy surrounds glyphosate.  The poor understanding of the toxicity profile has 
led to significant debates about the legislation around the use of glyphosate and the risk 
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to consumers. The first ban on glyphosate was in April 2014 by the Netherlands. They 
passed legislation banning the sale of glyphosate based herbicides for non-commercial 
use, but allowed industrial use to continue.192 France followed the Netherlands, asking 
suppliers of Roundup to be stopped in June, 2015.193 This was a non-binding request 
and sales of glyphosate will remain legal until 2022, when home gardening use will be 
banned.193 In March 2016, the licensing of glyphosate usage in Europe was due to be 
renewed, but was stalled due to France, Sweden, and the Netherlands objecting the 
renewal. Due to this objection, a temporary re-authorization of glyphosate usage was 
granted in June 2016.194, 195 This was followed by a license extraction of 18 months.196 
After this period has passed, the majority of the European Union members voted to 
allow the use of glyphosate to be extended for five more years.  
 
Despite the controversy of the re-licensing of glyphosate in Europe and the unknown 
toxicity profile of glyphosate, New Zealand would not consider banning glyphosate-
based pesticides. The reason for this is because New Zealand’s major source of income 
is from agricultural exports; in particular, dairy. If glyphosate was banned, it would 
likely have an effect on exports. This is because glyphosate prevents weeds, which 
increases output of crops by minimising weed competition and space with crops. Thus, 
not banning glyphosate in New Zealand is understandable because of the benefits it 
offers to farmers. These benefits likely outweigh the risk glyphosate has on consumers. 
If glyphosate was banned, there would be a large impact on agriculture because farmers 
are so reliant on it maintain high outputs. This might also be the reason for no complete 
ban in Europe. The New Zealand Environmental Protection Agency reviewed the safety 
of glyphosate in 2006. They employed Dr. Wayne Temple (ex-director of the National 
Poisons Centre) to review the current data on glyphosate carcinogenicity and suggest 
any action that should be taken around restricting or banning the use of the 
compound.197 Dr. Wayne Temple concluded that glyphosate did not require 
classification under the Hazardous Substances and New Organisms Regulations as a 
carcinogen or mutagen.197 This decision is understandable considering New Zealand 
farmers reliance on glyphosate-based herbicides to maintain high crop output. 
However, Dr. Temple’s reasoning for the decision to take no action was based on the 
genotoxicity and carcinogenicity data being of poor quality.197 This statement is 
interesting considering the worlds view on glyphosate toxicity; the data’s poor quality 
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and unreliability may be because glyphosate is a non-genotoxic carcinogen (discussed 
previously), which would be undetected in most systems. 
 
1.6.2 Concentrations of Xenoestrogens in Milk  
 
Chemical contaminants and the nutritional value of New Zealand milk are regularly 
monitored by the National Chemical Contaminants Programme (NCCP). Milk is the 
largest export of New Zealand; therefore, the truthfulness of the label is very important. 
For this reason, the regulations on milk are strict and checked by the NCCP regularly. 
Monitoring is carried out by the Crown Research Institutes (CRI) which specialise in 
monitoring chemical components (i.e. ESR). However, the analytical methods used by 
CRI might not be sensitive enough to monitor compounds below their limits; for 
example, if glyphosate had an MRL of 0.1 mg/L, and the detection limit of the 
analytical method used was 0.1 mg/L. This is concerning because xenoestrogens might 
be able to cause an effect at concentrations lower than the detection and action limits 
set by the NCCP. Whether or not a compound is monitored will depend on class of 
compound (i.e. pesticide, phytoestrogen, pharmaceuticals); for example, 
phytoestrogens will not be monitored because they are natural, therefore it is hard to 
control their concentration in food. Action limits are toxicity-based measures used by 
the NCCP; for example, action limits will be based upon acceptable daily intake (ADI) 
and tolerable daily intake (TDI) concentrations. The ADI and TDI are toxicity based 
measures of a compound in food and water which can be orally ingested daily over a 
life time without any adverse health risk to the consumer.198 An ADI will be used if the 
compound is intentionally added to food (e.g. food additives, and veterinary drugs and 
pesticide residues). Whereas, a TDI will be used if the compound is not intentionally 
added; for example, phytoestrogens from the cow’s diet which could be present in milk. 
There is conjecture around when an ADI or TDI should be used. Compounds can have 
an ADI and TDI which is the same because they are calculated using the same 
theoretical principals. These are calculated from the no observable adverse effect level 
(NOAEL). This is the highest exposure of a compound where no adverse effect is 
observed (e.g. no change in an enzyme concentration). The NOAEL is divided by a 
safety factor (usually 100) to get the ADI or TDI of a compound. However, a compound 
can have more than one NOAEL depending on the stated end point to the toxicity study; 
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for example, a compound could have an end point of the thickening of the endometrial 
lining or a change in the concentration of an enzyme in the liver. Depending on the 
stated endpoint, the NOAEL value can be very different.  
 
Pesticides have their own regulatory limit which is not toxicity based. Instead, it is the 
maximum concentration of residues which are legally acceptable in or on food or feed 
when the pesticide is applied correctly; these are called MRLs.  
 
For the purpose of this study, published ADIs will be used. If a compound does not 
have an ADI, it will be calculated with a hormonal related change as the endpoint where 
available. It is possible that xenoestrogens will cause a hormonal effect at exposures 
lower than their ADI. As previously mentioned, an ADI might be calculated from an 
NOAEL endpoint which is not a hormonal change. It is likely that this alternative 
change requires a concentration higher than what a hormonal change would require. 
Hormonal changes are likely to be caused by lower exposures because of the tight 
regulation of hormone concentrations in humans.  
 
An ADI might be exceeded; however, an ADI is the dose a compound can be received 
daily for a lifetime with no adverse effects. Therefore, if an ADI dose is exceeded for a 
short period of time, the risk cannot be assessed. For this reason, the acute reference 
dose (ARfD) was introduced in 1994. An ARfD is “an estimate of the amount a 
compound in food and/or drinking water, normally expressed on a body weight basis, 
that can be ingested in a period of 24 h or less without appreciable health risk to the 
consumer on the basis of all known facts at the time of the evaluation.”199 ARfD can 
also be used for slightly longer periods of time such as a week. This value is more useful 
for regulators because the acute exposure risk can be considered, which allows for a 
product to be removed from sale if the ARfD is exceeded for a short period of time.  
 
All of these measure (i.e. ADI, TDI, MRL, ARfD) only consider one single compound. 
However, it is possible that xenoestrogens can be additive – i.e. the cocktail effect. A 
hypothetical example of this would be if two xenoestrogens were present in a bottle of 
Milk. In this bottle of milk, xenoestrogen 1 was measured at a concentration of 50 mg/L 
and xenoestrogen 2 was measured at a concentration of 80 mg/L. If someone drunk 200 
mL of this milk, a dose of 10 mg of xenoestrogen 1 and 16 mg of xenoestrogen 2 would 
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be received. If a 62 kg person consumed this milk, a dose/kg bw of xenoestrogen 1 and 
xenoestrogen 2 would be 0.16 mg/kg bw and 0.25 mg/kg bw respectively. If the ADIs 
for xenoestrogen 1 and xenoestrogen 2 were 0.3 mg/kg bw/day and 0.5 mg/kg bw/day 
respectively for a hormonal change, there would be no risk and legal under legislation. 
There would be no risk because the dose/kg bw is below the ADI, and therefore legal. 
However, because there are more than one xenoestrogens present, they are part of part 
of a cocktail. These compounds are likely to have additive or synergistic effects. If these 
compounds have structural analogies, they are likely to exert their effects similarly. 
Therefore, the presence of these two compounds are likely to have a sum of effects of 
the individual compounds. Synergy is less likely, and complicated to explain. More 
than one possible mechanism of residues synergy is possible. For example, if a cell was 
exposed to two compounds (1 and 2) and 1 was toxic, but rapidly detoxified by UDP-
glucuronosyltransferases metabolism, and 2 is of low toxicity but inhibits UDP-
glucuronosyltransferases, 2 alone will have limited toxicity that is short lived because 
of the rapid metabolism.200 However, the situation would be different if both 1 and 2 
were administered together.200 This would result in an enhancement and prolonging of 
the toxicity of 1.200 The cocktail effect will, therefore, increase the effects of the 
individual. This could lead to an increased risk of hormone related cancers and 
decreased sperm concentration. Those who set regulations are likely to understand this 
concept but choose to ignore it. The reason for this is because compounds become hard 
to regulated as it is not completely understood how compounds interact with one 
another to cause their effect. Overall, the cocktail effect is likely to increase the risk to 
consumers, even though the individual compounds are below their ADIs.  
 
The concentrations of some endogenous estrogens and xenoestrogens have been 
measured in cow’s milk from different countries. The concentrations of these 
compounds have big variations from one country to another. In Table 1.1 the 
concentration ranges of some endogenous estrogens and xenoestrogens from different 
countries are shown. The ranges can be large; for example, genistein concentrations 
range from 0.04 x 10-3 to 157 x 10-3 (Table 1.1). The rages of concentrations are likely 
to be large because of differences in farming methods, weather, and regulations in each 
country. The growing conditions (e.g. soil fertility, climate) is likely to determine the 
species which are present in pasture. The growing condition in one country will be best 
suited to a species high in phytoestrogens better than another. Therefore, the conditions 
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and species present in pasture is likely to affect the concentration of phytoestrogens in 
milk. The country which suits the growing conditions of phytoestrogen containing 
pasture is likely to have higher concentrations in cow’s milk.  
 
Regulations from country to country is also likely to be different; in less developed 
countries, it is possible that the use of hormones in cattle is not illegal. Administering 
cattle with estrogens have shown to increase their weights, by converting feed into 
muscle, fat, and other tissues more efficiently.201 This leads to an increased production 
of milk per cow and the quantity of meat which can be made from the cattle; therefore, 
increasing the famers profit.201 In developed countries, this practice is illegal because 
of the possible side effects to the milk and meat from the cattle. It is likely that the 
concentration of hormones in these products would be increased because the increased 
circulating estrogen concentrations. The estrogens present in this milk and meat would 
be passed on to the consumer, possible increasing their exposure to estrogens. Some 
hormones are allowed to be used; in the USA, growth hormones can be given to cattle. 
The peptide growth hormone, bST, is administered to cows in the USA prolongs the 
production of milk in cows. bST works by slowing the breakdown rate of cells 
responsible for producing milk.202 This is achieved by directing nutrients to these cells 
extending the milk production period.202 It is possible that increasing the period of milk 
production could also increase the concentration of estrogens in the cow’s milk.  Some 
countries, including New Zealand, do not allow any hormones to be used in any animals 
which produce food products (e.g. cow, chicken) because of the possible toxicity to the 
consumer. However, administering antibiotics to cows is not illegal in most countries. 
The benefit of antibiotics in cows is so that disease is avoided; therefore, all the cow’s 
energy can be direct towards milk production, increasing the efficiency. However, 
compounds can still be present in cow’s milk without intentionally being added.  
  
A group of estrogen mimics which are typically found in cow’s milk are 
phytoestrogens. These compounds are produced by plants which mimic E2 in humans. 
The concentration of phytoestrogens in milk will be determine by the cow’s diet. This 
is very hard to control as all cows will eat different amounts. A countries climate is also 
likely to determine what is in a cow’s food; for example, cows in countries with an 
oceanic climate might have to be fed differently to ones in a tropical climate. The 
difference in these climates is that an oceanic climate is cool all year round with no wet 
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season with rainfall evenly distributed throughout the year; whereas, a tropical climate 
will have a distinct wet and dry season. Therefore, cows in tropical climates may require 
food supplementation because of droughts in the dry season. Cattles feed is typically 
supplemented with soy and grains to increase the energy density of the diet. If this is 
the case, the concentrations of phytoestrogens in milk from these cows are likely to be 
increased. This is because soy is known to contain genistein and daidzein.133 Cows in 
oceanic climates are less likely to require food supplementation because the climate is 
consistent throughout the year, therefore, can graze pasture continuously. New Zealand 
has an oceanic climate which is good for the persistent of red and white clover in 
pasture. As motioned previously, these species of clover contain the phytoestrogens 
daidzein and formononetin.155 Pasture containing red and white clover have shown to  
affect the concentration of phytoestrogens in milk; a cow eating higher concentration 
of clover lead to a concentration of phytoestrogens in their milk.155 
  
The large range of phytoestrogens in milk are shown in Table 1.1, especially daidzein. 
This is in line with higher clover containing pasture leads to higher concentrations of 
phytoestrogens in cow’s milk. The USA had the lowest daidzein concentration recorded 
of 2 x 10-5 mg/L. Whereas the higher concentration of daidzein (0.05 mg/L) in cow’s 
milk was recorded in the Czech Republic.20 Pasture in the USA does not contain high 
concentrations of clover compared with the Czech Republic, which contains high 
concentrations of clover.20 These figures match the thought that clover in pasture affects 
the concentration of phytoestrogens in milk. In New Zealand, red and white clover are 
common in pasture. It is likely that the New Zealand conditions are more similar to the 
Czech Republic. For this reason, it would be expected that the concentration of 
phytoestrogens in New Zealand are high. 
 
The New Zealand population’s daily exposure to endogenous estrogens and 
xenoestrogens from milk can be estimated. This is based upon the ranges of 
concentrations presented in Table 1.1, and the daily amount of milk drunk per capita. 
The most recent data on milk in New Zealand was reported by the Food and Agriculture 
Organization of the United Nations in 2013.150 However, this data was for the supply 
of milk per capita; therefore, for the purpose of this study it will be assumed that the 
New Zealand population consumes all of the whole liquid milk that it produces. Thus, 
the amount of whole milk drunk per capita is 132.21 mL per day.150 The theoretical 
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daily dose of endogenous estrogens are xenoestrogens are compared with their ADIs in 
Table 1.1.  
 
The compounds which are closest or exceed their ADIs are the endogenous estrogens; 
however, New Zealand does not allow hormone use in animals. Despite this, the 
estimated daily intake of E2 would be 0.03 mg. If a 62 kg person drunk this milk, the 
dose/kg bw would be 4.8 x 10-4 mg/kg bw. E2 has an ADI of 5 x 10-4, therefore the 
estimated dose/kg exceeds this. If this dose in milk is present for a period of time, it 
could lead to adverse effects; however, this might not exceed the ARfD of E2.  
 
The other xenoestrogens present in milk (i.e. phytoestrogens, mycotoxins, synthetic 
estrogen mimics) were measured at concentrations lower than endogenous estrogens. 
The estimated dose/kg bw was lower than their ADI apart from genistein. For these 
compounds it is possible that the ADIs set are not based on a hormonal change and 
instead used an NOAEL value for a change of enzyme concentration. This enzyme 
change could be an increase in the concentration of aspartate amino transferase. The 
dose required to cause this enzyme change compared with a hormonal change (e.g. 
thickening of the uterus lining) is likely to be very different. The dose is likely to be 
different because circulating hormone concentrations are tightly regulated due to their 
tight activity range. If there is a slight change in the circulating concentration of 
hormones, it is possible that an effect will occur. Therefore, two very different ADIs 
would be produced depending on the endpoint. If an endpoint for an enzyme change is 
used instead of a hormonal change to calculate the ADI, the consumer could be at risk. 
However, the relative estrogenic potency (REP) should be considered because these 
compounds are not as estrogenic as E2. The REP is the estrogenicity of a compound 
which is usually calculated by measuring a response of a compound binding to ERs 
(e.g. MELN cells produce light in response to binding to ERa). Phytoestrogens, 
mycotoxins, and synthetic estrogen mimics do not have the perfect requirements of 
binding to the LBC of ERs; therefore, the REPs of these compounds are low; for 
example, the REP of BPA is 5.1 x 10-3 % of E2. This means that a higher dose is 
required to achieve the same response as E2. However, these are calculated for a 
isolated compound at a time.  
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As discussed previously, these compounds are likely to be part of a cocktail of 
estrogenic compounds (e.g. E2 plus daidzein). If the cocktail of compounds is additive 
upon one another, the dose would be higher. The higher dose received could increase 
the risk of adverse effects; for example, increase the risk of breast cancer and decrease 
the concentration of sperm.  
 
New Zealand cow’s milk is monitored regularly by ESR; however, the concentrations 
of endogenous estrogens and xenoestrogens have not been published in literature 
before. The NCCP publish reports on and comment if compounds were found above a 
reporting limit, but do not publish the concentration if it is below this. If the 
concentrations of endogenous estrogens and xenoestrogens in New Zealand cow’s milk 
are similar to those shown in Table 1.1 it could be of concern. Also, these compounds 
are likely to be present as a cocktail, possibly being additive. Therefore, drinking cow’s 
milk could cause an increased risk of breast, prostate, and testicular cancer, decreased 
sperm count and sperm quality, and early onset of puberty. Thus, the New Zealand 
cow’s milk risk needs to be assessed by investigating the presence of endogenous 
estrogens and estrogen mimics. 
 
Table 1.1: Measured concentrations of xenoestrogens in cow’s milk and the estimated 
daily intake based on New Zealand population’s milk consumption data. The ADI 










E2 9 12 – 253 13 1.2 x 10-3 – 0.03 5 x 10-5            203 
EE2  0.035 14 – 0.11 14 4.69 x 10-6 – 1.47 x 10-5 4.3 x 10-5        204 
E1  24 15 – 566 16 3.22 x 10-3 – 0.07 8.6 x 10-4        204 
Zearalenone 0.046 17 – 0.76 18 6.17 x 10-6 – 1.01 x 10-4 5 x 10-4            203 
Genistein 0.04 19 – 157 20 5.36 x 10-6 – 0.02 1.5 x 10-4       205 
BPA 0.47 21 – 521 22 6.39 x 10-5 – 0.06 0.05             206 
Daidzein 0.02 19 – 50.2 20 2.68 x 10-6 – 6.73 x 10-3 N/A 
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1.7 Research aim 
 
The overall aim of the present study is to assess the risk to consumers of New Zealand 
cow’s milk in an estrogen mimic residue context. This will be achieved by the following 
research goals: 
 
1) Measure residue levels of estrogen mimics in New Zealand cow’s milk 
• Develop a method for the extraction and analysis of a range of natural 
estrogens and xenoestrogens (E2, daidzein, formononetin, zearalanone, 
genistein, EE2, BPA, and equol) from cow’s milk.  
• Validate the extraction and analytical methods through recovery and limits 
of detection experiments using high performance liquid chromatography – 
diode array detector (HPLC-DAD). 
• Assess the applicability of the extraction and analytical methods to cow’s 
milk. 
• Develop a method for the extraction and analysis of glyphosate from cow’s 
milk using liquid chromatography – mass spectrometry (LC – MS) 
2) Investigate potential microbiome-mediated increase in estrogenicity of dietary 
xenoestrogens in a model cow gut system  
• Set up a cow gut model system using fresh cow’s rumen tissue samples. 
• Check system to determine whether it is metabolically active (e.g. is equol 
produced from formononetin?). 
• Investigate microbiota – mediated metabolites of possible milk 
xenoestrogens using the cow gut model system. 
• Identify any metabolites produced using HPLC-MS, and nuclear magnetic 
resonance (NMR).  
3) Set the xenoestrogens residues levels and cow gut metabolite residues levels in 
a human risk context. 
• Calculate residues intakes as part of a normal human diet. 










Chapter 2 – Materials and Methods 
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Chapter 2 – Materials and Methods  
 






Authentic standards were purchased from Sigma-Aldrich, New Zealand unless stated 
otherwise.  
E2, EE2, BPA, formononetin, zearalenone, daidzein (LC laboratories, USA), genistein 





All solvents were HPLC grade and purchased from ECP Ltd, New Zealand unless stated 
otherwise.  
ACN, MeOH.  
 
General Chemicals  
 
All general chemicals were purchased from ECP Ltd, New Zealand unless stated 
otherwise.  
Anhydrous MgSO4, DCM, DMSO glacial acetic acid, hexane, inert N2 gas, Milli-Q 
water, NaCl, ethyl acetate, TBME, tris(hydroxymethyl)aminomethane (Sigma-Aldrich, 
New Zealand), 1M HCl, disodium EDTA (Sigma-Aldrich, New Zealand), ammonium 
formate, formic acid, Oxid™ Wilkins Chalgren anaerobic broth (Themo Fisher 






Laboratory, measuring cylinder (10 mL, 50 mL, 100 mL, 1L), 50 mL sterile 
polypropylene (PP) centrifuge tubes, autoclave, automatic pipette and tips (10 µL, 100 
µL, 1 mL), C18 reverse phase High Performance Liquid Chromatography column 
(Phenomenex, New Zealand), Acclaim Trinity Q1 liquid chromatography column 
(Thermo Fisher Scientific, New Zealand), C18 solid phase extraction (SPE) cartridges 
(500 mg, 6 mL) (Phenomenex, New Zealand) C18 octadecylsilane (ODS) SPE bulk 
sorbent (Agilent, USA), centrifuge (Multifuge 1 S-R, Heraeus, Hauna, Germany), glass 
pasture pipette, glass vial (20 mL), Glass wear (round bottom flasks, beakers, 
volumetric flasks, separating funnel), High Performance Liquid Chromatography 
System (Dionex, USA), Rotary evaporator (R-114, and a B-480 water bath, BÜCHI, 
Sigma Aldrich, Auckland, New Zealand), Schott bottles (150 mL, 200 mL, 500 mL, 1 




Sulfatase/b-glucuronidase from H.pomatia (≥10,000 units/g solid) (Sigma, USA), 
Proteinase K from Tritirachium album (≥30 units/mg protein) (Sigma-Aldrich, USA).  
 
2.2 Literature Review of the Concentrations of Xenoestrogens in Milk 
 
An extensive literature search was carried out using Google Scholar, Web of Science, 
Scifinder, and Scopus using the following key words; milk, estrogens, endocrine 
disruptors, and liquid chromatography, dated from 1990 onwards. From the search 
results, 21 papers were selected based upon the following selection criteria.  
1) Provided concentrations from milk samples.  
2) Provided analytical results. 
  3) Recoveries above 70%. 
4) Internal standards.  
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2.3  Methods 
 
2.3.1  Extraction of Xenoestrogens from Cow’s Milk 
 
This section was done in collaboration with Rachel Bennie. All extractions were carried 
out in duplicate. 
 
 
Extraction Method 1 
 
The quick, easy, cheap, effective, rugged, safe (QuEChERS) method 207 was applied 
for extraction of estrogenic compounds from milk. 10 mL of milk purchased from a 
local supermarket was measured into a 50 mL PP centrifuge tube and 15 mL ACN 
added. The mixture was shaken for 1 min then 6.0 g MgSO4 added and 1.5 g NaCl and 
shaken for 1 min. The mixture was centrifuged at 4400 rpm for 15 min. The supernatant 
was transferred to a 50 mL PP centrifuge tube containing 500 mg C18 sorbent and       
1.8 g MgSO4, it was shaken for 1 min then centrifuged at 4400 rpm for 15 min. The 
supernatant was collected and evaporated at 40°C using a rotary evaporator. The 
residue was dissolved in 500 µL 50% (v/v) MeOH (aq) and filtered using a 0.45 µm 
sterile Millipore filter and placed in HPLC vials for analysis.  
 
Extraction Method 2 
 
This method was adapted from Malekinejad et al. (2006).12 Briefly, 10 mL of              
80% (v/v, aq) MeOH was added to 10 mL of milk purchased from a local supermarket 
and vortexed mixed for 10 min then centrifuged at 2000 x g for 10 min at 4°C. The 
bottom layer was transferred to a 50 mL PP centrifuge tube and mixed with 10 mL 
hexane and centrifuged at 3500 x g for 10 min at 4°C. The upper hexane layer was 
removed, and 15 mL DCM added to the remaining liquid, vortexed for 15 sec, followed 
by slowly shaking by hand for 10 min. Then, the mixture was centrifuged at 2000 x g 
for 10 min at 4°C. The lower layer was transferred to a 50 mL PP centrifuge tube and 
the extraction repeated with 15 mL of DCM. The DCM phases were combined and 
homogonised by vortex. The solvent was evaporated off under a stream of N2 (g). The 
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residue was dissolved in 0.5 mL of MeOH and mixed by vortex, followed by the 
addition 9.5 mL Milli-Q. After homogenisation, the solution was passed through a C18 
SPE column (500 mg; 3 mL), which was activated with 5 mL MeOH and pre-
conditioned with 5 mL Milli-Q water. The analyte-containing column was washed with 
5 mL MilliQ water and dried with a stream of N2 (g). The analytes were eluted with 4 
mL MeOH and dried under a stream of N2 (g). The dried down particulate material was 
dissolved in 0.2 mL 50% MeOH (v/v, aq). The solution was filtered through a 0.45 µm 
sterile Millipore filter and placed in HPLC vials for analysis. 
 
Extraction Method 3  
 
This method was adapted from Wielogorska et al.208 Breifly, 12 mL 1% (v/v, aq) acetic 
acid in ACN was added to 10 mL of milk purchased form a local supermarket in a        
50 mL PP centrifuge tube, followed by the addition 2.5 g of MgSO4 and 1.0 g NaCl. 
The sample was shaken by hand for 1 min and centrifuged at 4500 rpm for 10 min at 
4°C. The supernatant was transferred to a 50 mL PP centrifuge tube and the solvent 
evaporated at 60°C under a stream on N2 (g). The sample were dissolved in 5 mL Milli-
Q water and passed through a C18 SPE column pre-conditioned with 3 mL of each 
TBME, MeOH, and MiliQ water. The column was washed with 3 mL Milli-Q water 
and the analytes eluted with 6 mL of 1% (v/v, aq) acetic acid in 10% (v/v) MeOH in 
TBME into a tube containing 100 µL DMSO. The solvent was evaporated at 60°C 
under a stream of N2 (g) and dissolved in 500 µL 50% (v/v, aq) MeOH and filtered 




2.4  Release of Xenoestrogens by De-Conjugation and Enzyme Digestion 
 




The buffer was prepared by dissolving 1.64 g sodium acetate in 50 mL of Milli-Q water. 
The pH was adjusted to 5.0 using 1M HCl. This was made up to 100 mL and making 




To 10 mL of milk purchased from a local supermarket, 10 mL                               
sulfatase/b-glucuronidase buffer was added to 10 mL of commercially purchased milk 
and vortexed for 30 sec. 0.5 mg of the enzyme was added to the buffered milk mixture 
and placed in a shaking incubator at 120 rpm at 37°C. The mixture was then extracted 
as described in Section 2.3.1, Extraction Method 1. Incubations were carried out in 
triplicate.  
 




The buffer was prepared by dissolving 0.36 g tris(hydroxymethyl)aminomethane in     
50 mL Milli-Q water. The pH was adjusted to 8.0 using 1M HCl. This was made up to 




To 10 mL of milk purchased from a local supermarket, 2 mL proteinase K buffer was 
added to 10 mL of commercially purchased milk and vortexed for 30 sec. 0.5 mg of the 
enzyme was added to the buffer milk mixture and placed in a shaking incubator 
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overnight at 120 rpm at 60°C overnight. The mixture was then extracted as described 
in Section 2.3.1, Extraction Method 1. Incubations were carried out in triplicate. 
 
2.5  Analytical Methods for the Measurement of Xenoestrogens 
 
2.5.1  HPLC 
 
All samples were analysed using a C18 reversed phase column using a stepped gradient. 
Each run included a solvent only and MeOH only blank. The ultraviolet (UV) 
absorbance was measured using a photo diode array detector (DAD) at 210, 235, 254, 
and 280 nm. The sampler was maintained at 4°C and each sample injection was 20 µL. 
Injections were carried out in dupilicate. The column oven temperature was 30°C. 
 
2.5.2  HPLC Preparation 
 
A Dionex HPLC system was used for all analyses. The injection needle was washed 
was 10% (v/v, aq) MeOH and primed 5 times with 10% (v/v, aq) MeOH. The HPLC 
system, was purged for 120 sec with a solvent mixture comprising of 99.9% ACN and 
0.1% (v/v, aq) glacial acetic acid, and a mixture of 99.9% Milli-Q water and               
0.1% (v/v, aq) glacial acetic acid.  
 
2.5.3  Mobile Phase 
 
Two elution buffers were used: Buffer A; a mixture of 99.9% Milli-Q water and 0.1% 
(v/v, aq) glacial acetic acid, Buffer B; a mixture of 99.9% ACN and                                 
0.1% (v/v, aq) glacial acetic acid. The same gradient (Table 2.1) was used for all 




Table 2.1: HPLC gradient for solvent A (a mixture of 99.9% Milli-Q water and 0.1% 
(v/v, aq) glacial acetic acid) and solvent B (a mixture of 99.9% ACN and          
0.1% (v/v, aq) glacial acetic acid) 
 0 min 0 – 20 min 20 – 25 min 25 – 30 min 
Solvent A (%) 95 50 95 95 
Solvent B (%) 5 50 5 5 
 
2.5.4  Identification of Compounds  
 
E2, daidzein, formononetin, zearalanone, genistein, EE2, BPA, and equol authentic 
standards were run before injection of samples. The sample peaks that co-
chromatographed with the authentic standard peaks and matching UV peak maxima 
were identified as either E2, daidzein, formononetin, zearalanone, genistein, EE2, BPA, 
and equol. 
 
2.5.5  Calibration Graph Preparation 
  
A 10 mg/L stock solution of analytical standards was prepared by dissolving 1 mg of 
analytical standard in 100 mL HPLC grade MeOH and 0.1% (v/v, aq) DMSO; it was 
inverted 20 times to dissolve the compound. The lower concentration standards were 
prepared by serial dilutions (Table 2.2). This was carried out for E2 (1.0 mg),               
EE2 (1.0 mg), formononetin (1.2 mg), diadzin (1.3 mg), genistein (1.3 mg),  











Table 2.2: Preparation of analytical standards  
Concentration of Standard Standard Diluted Methanol 
1.0 mg/L 10 mg/L (10 mL) 90 mL 
0.75 mg/L 1.0 mg/L (7.5 mL) 2.5 mL 
0.50 mg/L 0.75 mg/L (6.7 mL) 3.3 mL 
0.25 mg/L 0.50 mg/L (5 mL) 5 mL 
0.10 mg/L 0.25 mg/L (4 mL) 6 mL 
0.05 mg/L 0.10 mg/L (5 mL) 5 mL 
 
2.6  Analysis of Glyphosate in Milk 
 
2.6.1  Extraction of Glyphosate from Cow’s Milk 
 
The method developed by Chamkasem et al. was used to extract glyphosate from 
milk.209 Briefly, extracting solvent was prepared by mixing 572 µL glacial acetic acid 
with 0.74 g Na2EDTA and made up to 200 mL with Milli-Q water.  3 mL of this solution 
was added to 1 mL milk purchased from a local supermarket in a 15 mL PP centrifuge 
tube and shaken by shaking incubator at 120 rpm for 10 min. It was then centrifuged at 
3000 rpm for 5 min. 3 mL of the supernatant was passed through a C18 SPE column 
(500 mg; 3 mL), previously conditioned with 2 mL MeOH and 2 mL extracting solvent. 
The final 1 mL of the extract was collected into HPLC vials for analysis. This was 
carried out for 5 milk samples. 
 
2.6.2  Analysis of Glyphosate by LC-MS  
 
Because glyphosate does not have a chromophore, HPLC–DAD detection could not be 
used. The mobile phase and gradient was applied from Chamkasem et al.209 All mass 
spectrometry was carried out by Dr. Marie Squire, the School of Physical and Chemical 







One elution buffer was used for all analysis. A solution of 500 mM ammonium formate/ 
formic acid (pH 2.9) was prepared by dissolving 15.76 g of ammonium formate in      
300 mL of Milli-Q water. The pH was adjusted to 2.9 with formic acid using a pH 
meter. This solution was then made up to 500 mL with Milli-Q water. The final           
LC-MS mobile phase was prepared by mixing 100 mL of the 500 mM buffer solution 
with 900 mL Milli-Q water, so the final concentration of ammonium formate/formic 




LC-MS was carried out by Dr. Marie Squire using a Maxis 4G spectrometer operated 
in high resolution mode with a positive ESI source. The acquisition parameters are 
shown in Table 2.3 An Acclaim Trinity Q1 LC column with a C18 SecurityGuad guard 
column was used at 35°C for all analysis. A sample inject volume of 10 µL was used. 
The flow rate was 0.5 mL/min for a total run time of 6 min. 
 
Table 2.3: The acquisition parameter used for the Maxis 4G spectrometer for 
glyphosate analysis in New Zealand cow’s milk sample extracts.  
Scan Begin 100 m/z 
Scan End 3000 m/z 
Set Capillary 4000 V 
Set Nebulizer 1.0 Bar 
Set Dry Heater 200°C 




2.7  Cow Rumen Metabolism Model System 
 
2.7.1  Sterilisation of Equipment Used for Model Cow Rumen Studies 
 
All glassware, metal instruments and media were autoclaved at 121°C, 15 psi for           
20 min.   
 
2.7.2  Media Preparation 
 
Wilkens Chalgren broth was made by dissolving 13.37 g Wilkens Charlgren powder 
into 405 mL of Milli-Q water. This was then autoclaved as described in Section 2.7.1. 
 
2.7.3  Incubation of Test Substance in the Cow Rumen Model System 
 
Cows rumen samples were obtained from Silver Fern Farms. Slices (4 x 2 cm) of rumen 
were incubated in 50 mL sterile PP centrifuge tubes containing 15 mL of Wilkins 
Chalgren anaerobic broth (See Section 2.7.2). To the incubation, 10 mL of 
formononetin (10 mg/L) was added, and the culture was placed in a shaking incubator 
at 120 rpm at 37°C for 1, 2 or 3 days in triplicate. Three controls were set up in duplicate 
in 50 mL sterile PP centrifuge tubes (Table. 2.4) placed in a shaking incubator at          
120 rpm at 37°C for 1, 2 or 3 days. 
 
Table 2.4: Preparation of controls for cow’s rumen incubation studies 






anaerobic broth + 
test compound 
Wilkins Chalgren 





2.7.4  Extraction of Rumen Incubate 
 
After incubation, the culture solution was placed in a separating funnel with 45 mL 
ethyl acetate. The funnel was capped and inverted 15 times and the layers allowed to 
separate. Once separated, the organic (upper) layer was removed and the solvent 
evaporated at 50°C using a rotary evaporator. The residue was dissolved in 1 mL       
50% (v/v, aq) MeOH and filtered through a 0.45 µm sterile Millipore filter and placed 
in a HPLC vials for analysis. The HPLC-MS method used as described in Section 2.6.3.   
 
2.8  In-silico Molecular Modelling Studies of Glyphosate  
 
The molecular docking studies were carried out using Schrödinger Suite-Small-
Molecule Drug Discovery Suite 2017-1 (Schrödinger, LLC, New York, USA) to 
determine the likelihood that glyphosate would bind to the LBC of the estrogen 
receptor. Maestro (Schrödinger Release 2017-1: Mastro, Schrödinger LLC, New York, 
NY, 2017) was used as the interface for preparing ERα and ligands for the study.  
 
2.8.1  Protein Preparation  
 
The X-ray crystallographic coordinates of ERα were taken from the Protein Data Bank 
(PDB; http://www.rcsb.org), the X-ray crystal structure of ERα complexed with E2 
(PDB entry 1ERE) was used. This crystal structure of ERα has four identical chains 
(i.e. Chain A, Chain B, Chain C, and Chain D), each chain has a docked ligand (i.e. 
E2). Chain A was arbitrarily used as the ligand-receptor subunit for this docking study, 
Chain B, Chain C, and Chain D were deleted. Missing amino acid residues (Ser 305, 
Tyr 331, Asp 332, Pro 333, Thr 334, Arg 335, Pro 336, Phe 337, Arg 548, Leu 549) 
based on the protein’s primary sequence were added to complete the protein structure 
using the Schrödinger ‘Prime’ command. Besides the ligand, a single water molecule 
is present in the protein-ligand complex, this is considered important for ligand-receptor 
interactions and so was kept, other water molecules (probably originating from the 
solvent) were removed.88 A restrained minimization was run to re-orientate side-chain 
hydroxyl groups and alleviate potential steric clashes by user-selected root-mean-
 65 
square deviations (RMSD) with a tolerance of 0.3 Å.  
 
2.8.2  Receptor Grid Generation.  
 
The receptor grid was set up and generated from the Receptor Grid Generation panel 
of Glide (Schrödinger Release 2017-1: Glide, Schrödinger LLC, New York, NY, 2017). 
The natural ligand binding site was used for this docking study, but the original bound 
ligand (E2) was excluded.  
 
2.8.3  Preparation of Ligands  
 
Glyphosate was built and prepared using LigPrep to set the ionization state at pH 7.0 ± 
2 and generate possible tautomers. (Schrödinger Release 2017-1: LigPrep, Schrödinger 
LLC, New York, NY, 2017).  
 
2.8.4  Ligand Docking and Calculations  
 
Rigid receptor-flexible ligand docking calculations were performed using Glide in extra 
precision (XP) mode. Glyphosate was conformationally sampled in the LBC and its 
pose was scored in terms of its E-model. Since the E-model has a more significant 
weighting of the force field (electrostatic and Van der Waals energies), it is well-suited 
to pose selection. In this docking experiment, GlideScore and DockScore were 
determined. GlideScore approximates ligand binding free energy, it has many 
components, including force field (electrostatic, Van der Waals) contributions and 
factors rewarding or penalizing interactions known to influence ligand binding. The 
resulting docking poses were ranked using DockScore which is the sum of the 
GlideScore and the Epik (i.e. state penalty for ligand protonation and tautomeric). The 
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Chapter 3 – Results 
 
3.1  Concentrations of Endogenous Estrogens and Xenoestrogens in Milk 
 
Searching the key databases with the selected key words, resulted in 21 references 
based on the selection criteria listed in Section 2.2. The compounds that have been 
measured to date in bovine milk are the natural estrogens (E1, E2, E3, and E1S), 
phytoestrogens (formononetin, equol, biochanin A, daidzein, and genistein), 
mycotoxins (zearalenone and its metabolite a-zearalenone), and estrogen mimics (EE2, 
BPA, NP, and octylphenol). The concentrations differ between countries and type of 
milk. Table 3.1 shows the concentrations of estrogens and estrogen mimics, the country, 
and the reported concentration in specific milk types. Table 3.2 shows the reported 
concentrations of estrogens and estrogen mimics in milk which did not specify the type.  
 
Table 3.1: Published concentrations of endogenous estrogens and xenoestrogens in 
specific types of cow’s milk (organic [O], raw [R], whole [W], half skim [HS], 
and skim [S]) from different countries.  








































































 Germany 26.6 [S]211 
E3 Iran 0.12 [O]12  
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Formononetin Finland 45 [O]158 































Zearalenone China 0.01 [R]17 
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Table 3.2: Published concentrations of endogenous estrogens and xenoestrogens in un-
specified types of cow’s milk from different countries.  





 France 1.52217 
E2 China 12.50218 








Formononetin France 12220 
Equol Finland 616158 
 France 780220 
Biochanin A France 7220 
Daidzein France 18220 
 United States 0.2419 
Genistein France 9220 
 United States 0.3519  
Zearalenone China 20517 
a-Zearalenone China 0.0317 



















3.2  Identification of Compounds  
 
A peak’s identity in milk sample extracts was confirmed by comparison with retention 
times (tR) of authentic standards and its UV-spectrum. These were compared with 
authentic standards that had been purchased. A comparison for a BPA authentic 
standard and a suspected BPA peak present in milk sample extract is shown in Figs. 3.1 









Figure 3.1: A typical HPLC trace for BPA authentic standard (tR = 20.870 min) (1 mg/L 
in ACN) (top) and a suspected BPA peak (tR= 20.867 min) in a milk sample 






Figure 3.2: Typical UV spectra of BPA authentic standard (1mg/L in ACN) (top) and 
a suspected BPA peak in a milk sample extract (bottom) injections using HPLC-
DAD. 
 
3.3  Validation of the HPLC-DAD analytical method for Endogenous 
Estrogens and Xenoestrogens 
 
The separation of E2 and xenoestrogens (daidzein, genistein, formononetin, BPA, EE2, 
and zearalenone) was successful using the HPLC-DAD method described in Section 
2.5 (Fig. 3.3). The peaks were well separated and were sharp with no shoulders (Fig. 






Table 3.3: The HPLC retention times of E2 and xenoestrogens (for solvent systems see 
Section 2.5.3) 



















Figure 3.3: An HPLC trace for a solution of 50% MeOH (v/v, aq) containing daidzein, 
genistein, formononetin, BPA, E2, EE2 and zearalenone authentic standards 
injection. Authentic standards separated within 10 min. Detection at λ 280 nm.  
 
3.4  HPLC-DAD Limit of Determination and Limit of Quantification for 
Xenoestrogens 
 
Method detection and quantification limits are presented in Table 3.4. The limit of 
determination (LOD) values for E2, EE2, formononetin, genistein, daidzein, equol, and 
 
 76 
BPA were measured by the sound to noise ratio of two MeOH blanks. The LODs ranged 
from 0.0025 – 0.1 mg/L for E2, EE2, formononetin, genistein, daidzein, equol, and 
BPA. The limit of quantification (LOQ) being at least 10-fold more concentrated that 
the LOD, ranging from 0.05 – 1 mg/L for E2 and xenoestrogens. A typical 
chromatogram of a sample blank, HPLC grade MeOH (Fig. 3.4), and the detection limit 
and quantification limit chromatogram of daidzein is shown in Figs 3.5 and 3.6 
respectively.   
 
Table 3.4: LOD and LOQ for E2, EE2, formononetin, genistein, daidzein, equol, and 
BPA using HPLC-UV. 
Compound LOD (mg/L) LOQ (mg/L) 
E2 0.1000 1.00 
EE2 0.0500 0.10 
Formononetin 0.0050 0.05 
Genistein 0.0050 0.10 
Daidzein 0.0025 0.05 
Equol 0.0100 0.05 
BPA 0.0050 0.01 














Figure 3.4: A typical HPLC trace of the sample blank, HPLC grade MeOH. Detection 




Figure 3.5: Typical HPLC trace showing the LOD (0.0025 mg/L) for daidzen (tR = 





Figure 3.6: Typical HPLC trace showing the LOQ for dadzein (tR = 15.623 min) (0.05 
mg/L) in HPLC grade MeOH. Detection at λ 280 nm.  
 
3.5  Calibration graphs for Endogenous Estrogens and Xenoestrogens 
 
The calibration curves for E2, daidzein, formononetin, zearalanone, genistein, EE2, 
BPA and equol all have good linear regression with R2 values in the range of                
0.97 – 0.99 (Fig. 3.7). The linear nature of the calibration graphs allows for the reliable 
calculation of concentrations of E2, daidzein, formononetin, zearalanone, genistein, 





Figure 3.7: Calibration graphs for E2, daidzein, formononetin, zearalanone, genistein, 
EE2, BPA, and equol authentic standards. All show good linear regression with 
























































































































































3.6  Extraction Recoveries 
 
Milk that was not found to contain xenoestrogens in previous analyses (i.e. 
xenoestrogen-free) was used for the recovery experiments. The recoveries for E2, EE2, 
formononetin, daidzein genistain, equol, BPA, and zearalenone were carried out by 
spiking milk samples found to not contain xenoestrogens and extracted follow the 
method outlined in Section 2.3.1, Method 1. Spiked milk sample extracts were analysed 
using HPLC-DAD (see Section 2.5). The extraction recoveries are presented in Table 
3.5. Recoveries range from 62 % for BPA to 94% for EE2. 
 
Table 3.5: Mean recoveries of xenoestrogens spiked at 1 mg/L in xenoestrogen-free 
milk (n = 3). 
Compound Mean Recovery ± SD (%) 
E2 67.44 ± 8.0 
EE2 94.29 ± 12.38 
Formononetin 83.70 ± 9.56 
Daidzein 72.46 ± 13.69 
Genistein 91.13 ± 9.19 
Equol 78.84 ± 9.56 
BPA 61.96 ± 7.81 
Zearalenone 87.74 ± 12.52 
 
3.7  Analysis of Endogenous Estrogens and Xenoestrogens in Milk 
 
E2, EE2, formononetin, daidzein, genistein, equol, BPA, and zearalenone were 
measured in extracted milk samples using HPLC-DAD (see Section 2.5), a typical 
chromatogram of an extracted milk sample is shown in Fig 3.8. A total of 30 bottles of 
milk purchased at a local supermarket were extracted and analysed (Table 3.6).  
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Table 3.6: Calculated peak areas and concentrations of endogenous estrogens and xenoestrogens (E2, EE2, formononetin, daidzein, genistein 
equol, BPA, zearalenone) in 30 commercially available New Zealand Cow’s milk samples measured using HPLC-DAD.  
 
Sample 
Peak Area (mAU)/ Concentration in mg/L 
E2 EE2 Formononetin Daidzein Genistein Equol BPA Zearalenone 
1 ND ND ND ND ND ND ND ND 
2 ND ND ND ND ND ND ND ND 
3 ND ND ND ND ND ND ND ND 
4 ND ND ND ND ND ND ND ND 
5 ND ND ND ND ND ND ND ND 
6 ND ND ND ND ND ND ND ND 
7 ND ND ND ND ND ND ND ND 
8 ND ND ND ND ND ND 0.659/ 0.041 ND 
9 ND ND ND ND ND ND ND ND 
10 ND ND ND ND ND ND ND ND 
11 ND ND ND ND ND ND ND ND 
12 ND ND ND ND ND ND ND ND 
13 ND ND ND ND ND ND ND ND 
14 ND ND ND ND ND ND 0.625/ 0.039 ND 
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15 ND ND ND ND ND ND 0.293/ 0.019 ND 
16 ND ND ND ND ND ND 0.146/ 0.010 ND 
17 ND ND ND ND ND ND 0.200/ 0.013 ND 
18 ND ND ND 0.185/ 0.021 ND ND Detected ND 
19 ND ND ND ND ND ND 0.343/ 0.022 ND 
20 ND ND ND ND ND ND 0.110/ 0.007 ND 
21 ND ND ND ND ND ND ND ND 
22 ND ND ND ND ND ND ND ND 
23 ND ND ND ND ND ND ND ND 
24 ND ND ND ND ND ND ND ND 
25 ND ND ND ND ND ND ND ND 
26 ND ND ND ND ND ND 0.112/ 0.008 ND 
27 ND ND ND ND ND ND ND ND 
28 ND ND ND ND ND ND ND ND 
29 ND ND ND ND ND ND ND ND 
30 ND ND ND ND ND ND ND ND 
 
ND. = Not detected 
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Figure 3.8: A typical HPLC trace of an extracted milk sample showing a BPA peak at 
tR = 20.867 min using HPLC-DAD. Detection at λ 280 nm.  
 
3.7.1 Source of BPA in Milk Sample Extracts 
 
The source of BPA was investigated by contacting a milk company and a farming 
equipment. Meadow Fresh were contacted about what their plastic milk bottles and 
cardboard milk cartons were made of. An employee of Meadow Fresh stated that the 
plastic milk bottles are made of food grade high-density polyethylene (HDPE), and the 
milk cartons are made of paper with a poly ethylene liner.  
 
Skellerup were contacted regarding farming equipment, in particular the claw bowl and 
milk tubing. Skellerup were contacted by email on 3 occasions, email replies were 
received indicating that my enquiry had been passed on the technical manager and 
general manager, and to expect a reply. However, no reply was received.  
 
3.8  Metabolite identification 
 
An unidentified peak often appeared in milk sample extracts (tR = 13.5 min) (Fig. 3.9). 
It was thought that the unidentified peak might be a metabolite of equol because the 
UV spectrum obtained by HPLC-UV was similar to the UV spectrum of the authentic 
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standard of equol. The UV maximum of equol was 196, 221, and 281, compared with 
the unknown peak of 193, 228, and 272.  
 
Figure 3.9: Typical HPLC trace of a milk sample extract showing that unidentified 
peak, suspected to be a metabolite (top) with a tR = 13.540 min. The UV spectrum 
of the unknown peak (bottom) is similar to equol (top), sharing similar UV 
maxima, but slightly shifted. 
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The suspected metabolite peak was collected using the fraction collection function on 
the HPLC system. The fraction was analysed by direct inject probe mass spectrometry 
using a Maxis 4G spectrometer operated in high resolution mode with a positive ESI 
source. Analysis was carried out by Dr. Marie Squire. The fraction collected peak (5 
µL) had an ion of 349.1263 m/z (Fig. 3.10).  
 
Figure 3.10: Mass spectrum of the unidentified peak; a suspected metabolite of equol, 
with m/z = 349.1263 
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3.8.2  Nuclear Magnetic Resonance Spectroscopy  
 
The suspected metabolite peak fraction was dried at 60°C with a stream of nitrogen and 
the residue dissolved in 2 mL [U-2H]-DMSO and subjected to nuclear magnetic 
resonance spectroscopy (NMR). Unfortunately, the concentration of the compound was 














Figure 3.11: 1H NMR spectrum of the suspected metabolite peak fraction in 2 mL       
[U-2H]-DMSO. Only the solvent peaks, DMSO and DMSO-H2O were observed 
due to the concentration of the suspected metabolite being too low. 
 
3.9  Release of Xenoestrogens by De-Conjugation and Enzyme Digest 
 
3.9.1  Cleavage of Sulfated and Glucuronidated Xenoestrogens using the 
Enzyme Sulfatase/b-Glucuronidase from H. pomatia 
 
Milk purchased from a local supermarket was incubated with sulfatase/b-glucuronidase 
overnight buffered at pH 5.0 at 37°C in a shaking incubator extracted and analysed by 
HPLC-DAD. A peak of genistein (tR = 18.56 min) appeared in extracts of milk treated 




typical chromatogram of milk extracted after incubation with sulfatase/b-glucuronidase 
is shown in Figure 3.12.  
 
3.9.2  Release of Xenoestrogens by Proteinase K Digestion 
 
Milk purchased from a local supermarket was incubated with proteinase K overnight 
buffered at pH 8.0 at 60°C in a shaking incubator extracted and analysed by HPLC-
DAD. No extra identifiable peaks were present in extracts of milk treated with 
proteinase K. A typical chromatogram of milk extracted after incubation with 




Figure 3.12: A typical HPLC chromatogram of before (top) and after extracts of milk 
treated with sulfatase/b-glucuronidase (middle), and proteinase K (bottom). A 
peak of genistein (tR = 18.56 min) appeared after treatment with sulfatase/b-
glucuronidase (top). No extra identifiable peaks appeared after treatment with 
proteinase K (bottom). 
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3.10 Extraction and Analysis of Glyphosate in New Zealand Milk 
 
Glyphosate residues were measured in extracted milk samples purchased from a local 
supermarket and extracted following the method outlined in Section 2.5.1. Analysis of 
extracted milk samples was carried out by LC-MS (Section 2.6.1). LC-MS of 
glyphosate standards did not produce an ion consistent with glyphosate; therefore, the 
unusual step of direct inject probe mass spectrometry because an ion consistent with 
glyphosate produced (0.001 mg/L, Fig. 3.13). An extracted milk sample was analysed 
by direct inject probe mass spectrometry; no ion was produced consistent with the ion 
produced in the glyphosate standard (Fig. 3.14).  
 
 
Figure 3.13: Mass spectrum of a glyphosate standard (0.001 mg/L) in Milli-q water by 





Figure 3.14: A typical mass spectrum of a milk sample extract analysed by direct inject 
probe mass spectrometry. No ions were produced which matched the ion 
produced in a glyphosate standard.   
 
3.11  Metabolism of Xenoestrogens with Cow’s Rumen Model System 
 
Wilkins Chalgren broth spiked with formononetin (10 mg/L) was incubated with cow 
rumen slices (4 x 3 cm) sampled daily for 3 days. The incubate was extracted and 
analysed by HPLC-DAD. A suspected equol peak appeared after the incubation with 
cow rumen slices not identified in controls (Fig. 3.15). The identity of equol was 
confirmed by spiking extracts with equol authentic standard. This suggests that the 

































Figure 3.15: Typical HPLC trace of day 1,2, and 3 sample extracts of cow rumen slices 
(4 x 2 cm) incubated with formononetin (tR = 15.6 min). A suspected equol peak 






3.12  In-silico Glyphosate/ERa Binding Studies  
 
Using ERa X-ray crystal structure coordinates (1ERE) a model of human ERa was 
built in Schrödinger (see Section 2.8). This was used for glyphosate docking studies. 
Rigid docking was used. This means that the conformation of the receptor is the same 
as the ERa/E2 complex and is used to determine the fit of another potential ligand to 
the LBC arranged to bind E2. This results in less favourable calculated binding energies 
or no pose docked. In contrast, more flexible ligands have more poses within the LBC, 
the given calculated binding energies show the conformation of ligand that gives more 
favoured interactions between the ligand and receptor complex. 
 
The in-silico model shows that glyphosate has some structural analogy with E2 in the 
ERa active site (Fig. 3.14), with a docking score of -21.55 kJ/mol compared to E2 
which has a docking score of -41.76 kJ/mol. Glyphosate (Fig. 3.16) orientates in the 
LBC in such a way that the two -OH groups of the phosphate group hydrogen bonds 
with Glu353,  and one phosphate -OH group hydrogen bonds with Arg394 (Fig. 3.16). 
The -NH- group of glyphosate forms a hydrogen bond with Leu346, which is not seen 
when E2 is bound (Fig. 3.14). One other key difference is that glyphosate does not 
interact with His524, whereas E2 does (Fig. 3.16). The distance of glyphosate from 

































Figure 3.16: Glyphosate (top) bound in the LBC of ER shows similar bonds as E2 
(middle) bound (Glu353, Arg394, and a water molecule), with an extra bond to 
Leu346 that does not form with E2. Glyphosate (top and bottom) does not form 
a hydrogen bond to His524 which E2 (middle) does, and is far away from the 
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Chapter 4 – Discussion 
 
The aim of this study was to carry out a risk assessment of New Zealand cow’s milk in 
an estrogen mimic context. The study successfully evaluated methods for the extraction 
of endogenous estrogens and xenoestrogens. The chosen method was used for the 
extraction and measurement of endogenous estrogens (E2) and xenoestrogens (EE2, 
formononetin, genistein, daidzein, equol, BPA) in New Zealand cow’s milk samples. 
The method had recoveries ranging from 62 – 94%, LODs ranging from 0.0025 – 0.1 
mg/L and LOQs ranging from 0.05 – 1 mg/L for the target compounds. The chosen 
method identified genistein, daidzein, and BPA in New Zealand milk sample extracts 
at concentrations ranging 0.007 – 0.041 mg/L. In milk sample extracts a peak of an 
unknown identity often appeared. This peak had a tR = 13.540 min and a UV spectrum 
very similar to equol; however, it eluted sooner than equol. It was thought that this peak 
might be a equol metabolite. The unidentified peak was isolated by HPLC fraction 
collection and investigated by MS and NMR. The mass spectrum of the residue was 
349.1263 m/z; however, no information could be gained from NMR due to the low 
concentration of the residue. The unidentified peaks identity was speculated based on 
common metabolism route and m/z; however, was not identified. The presence of 
glyphosate in cow’s milk was investigated in light of the presence of glyphosate in ice 
cream samples for the United Kingdom. A previously accepted extraction method was 
used to determine the presence of glyphosate, due to the low concentrations published, 
direct inject probe mass spectroscopy was utilised. In New Zealand cow’s milk samples 
(n = 5), no mass ion consistent with glyphosate was identified. A cow gut model system 
was set up and used to investigate the metabolism of phytoestrogens. Briefly. Cow 
rumen slices were cut into strips (4 x 2 cm) and incubated with anaerobic broth spiked 
with phytoestrogens (10 mg/L). A phytoestrogen found in clover, formononetin, was 
incubated in this system. When the broth containing formononetin was extracted, a 
well-known gut microbiota metabolite, equol was identified. This indicates that the 
system is capable of producing metabolites during incubation However, no unknown 
metabolites of formononetin were identified.  
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4.1  Evaluation of Extraction Methods for the Extraction of Xenoestrogens 
from Cow’s Milk 
 
It is well documented in scientific literature that endogenous estrogens and 
xenoestrogens are present in cow’s milk; therefore, there has been methods developed 
previously for the extraction of these compounds in cow’s milk.12-15, 17, 20-22, 133, 152, 155, 
157, 158, 210, 212-218, 220-236 In view of this, it was decided that one of the available methods 
would be used and modified for this study. This was decided because developing a new 
method can be laborious and time consuming. The purpose of the pilot study was to 
investigate the presence of endogenous estrogens and xenoestrogens in milk, not 
develop a new method to do this. The study modified published methods by using 
HPLC-DAD rather than LC-MS because of the ease of data analysis by HPLC-DAD. 
LC-MS is a highly sensitive analytical technique; it produces a peak for any component 
in the sample which is volatile. Manual peak analysis is therefore required. The MS can 
also cause the compound to split leading to m/z which might not be expected. In 
extracted milk samples where there is more than one compound, this could lead to the 
compounds being missed. Whereas, a compound requires a chromophore for HPLC-
DAD to be detect. HPLC-DAD can further discriminate based on the UV maximum of 
compounds by setting the detection wavelength. This allows for more discrimination 
of results as all compounds of interest could be analysed at one wavelength. Therefore, 
data analysis is cleaner, easier, and quicker by HPLC-DAD due to it being more 
selective on the data displayed. 
 
Methods for the extraction of endogenous estrogens and xenoestrogens were chosen 
based on their attributes (e.g. time taken to carry out, robustness). Many of the methods 
published in literature are designed to extract a single group of compounds); for 
example, Goyon et al. published a method for the determination of steroid hormones 
(e.g. E1, E2, E3, progesterone, testosterone) and Steinshamn et al. published a method 
for the determination phytoestrogens (e.g. formononetin, equol, genistein).155, 235 
Methods which are designed to extract one group of compounds should have better 
recoveries compared with a method which extracts all groups of xenoestrogens. The 
reason for this is because each group of compounds have different properties (e.g. 
solubility); therefore, different solvents are used to achieve the maximum extraction of 
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compounds. This is important when extracting endogenous estrogens and 
xenoestrogens from milk. Milk is a high fat matrix which these compounds are very 
soluble in due to their hydrophobic nature; therefore, choosing a solvent which the 
target compounds are more soluble in compared with the lipid in milk needs to be 
selected. However, not all groups of compounds will be equally soluble in the chosen 
solvent, which leads to different recovery efficiencies. Thus, it is likely that multiple 
methods should be used to achieve the best recoveries for all groups of compounds; 
however, this is not cost or time efficient, unless only one group of compounds are 
wanting to be measured. The aim of the study was to evaluate the risk of New Zealand 
cow’s milk in an estrogen mimic context; therefore, methods capable of extracting a 
broad range of endogenous estrogens and xenoestrogens were investigated. 
 
4.1.1  Evaluation of Methods for the Extraction of Endogenous Estrogens and 
Xenoestrogens from Cow’s Milk 
 
Three extraction methods were evaluated for the extraction of endogenous estrogens 
and xenoestrogens from cow’s milk. This allowed for the best method capable of 
extracting the study’s target compounds to be picked. Of the three methods chosen to 
investigate, two of these were designed to extract a broad range of compounds. These 
were Method 1 published by Socas-Rodríguez et al., 2017, and Method 3 published by 
Wielogorska et al., 2014.207, 208 The other method selected was one which extracted 
only endogenous estrogens; this was published by Malekinejad et al., 2006 (Method 
2).12 One targeted extraction method for endogenous estrogens was picked to compare 
differences in effectiveness of a targeted extraction method compared with a broad 
compound extraction method. A brief description of these are shown in Table 4.1. After 
these extraction methods were investigated, Method 1 was chosen to be used to extract 
endogenous estrogens and xenoestrogens form cow’s milk samples. The reason for 
choosing this method was because it extracted a broad range of compounds and was 





Table 4.1: Summary of the three chosen methods for the extraction of endogenous 
estrogens and xenoestrogens from New Zealand cow’s milk samples.  
Method 1  
(Socas-Rodríguez et al., 2017) 
Method 2  
(Malekinejad et al., 2006) 
Method 3  
(Wielogorska et al., 2014) 
 
10 mL Milk + 15 mL 
ACN, shaken, + 6 g 
MgSO4 + 1.5 g NaCl, 
shaken, centrifuge, take 
supernatant + 500 mg 
C18 sobent + 1.8 g 
MgSO4, shaken, 
centrifuge, evaporate, 
dissolve in 50 % MeOH, 
analyse.  
 
10 mL milk + 80 % (v/v, 
aq) MeOH, vortex, 
centrifuge, bottom layer 
kept + hexane centrifuge, 
top layer kept, + DCM to 
remaining liquid, vortex, 
slow shaking, centrifuge, 
lower layer kept, repeat 
DCM step, combine lower 
layers, vortex, evaporate 
with stream of N2 (g), 
dissolve in MeOH, 
vortex, + Milli-Q, C18 
SPE column, dry SPE 
column (stream of N2 
(g)), elute with MeOH, 
evaporate, dissolve in 
50% MeOH, analyse.  
 
10 mL milk + 1 % (v/v, 
aq) acetic acid in ACN + 
2.5 g MgSO4 + 1.0 g 
NaCl, shaken, centrifuge, 
supernatant evaporate 
with stream of N2 (g), 
dissolved in Milli-Q, C18 
SPE column, column 
washed, analytes eluted 
with 1% (v/v, aq) acetic 
acid in 10% (v/v) MeOH 
in TBME, evaporate with 
stream of N2 (g), dissolve, 
in 50 % MeOH, analyse 
 
Reasons for Selecting Method 1 
 
All methods had 3 major components to them: 1) defatting of the milk; 2) extraction 
and clean-up of the target compounds; 3) concentrating and analysis of compounds. 
The slowest of the three selected methods was Method 2, with the fastest being Method 
1. Milk samples extracted using Method 2 used two rounds of LLE and had the most 
steps in the extraction, which is likely why it was the longest to carry out. Method 1 
was likely the fastest to carry out because a rotary evaporator was used to dry solvents, 
and the SPE clean-up was carried out by using a centrifuge. Whereas, Methods 2 and 3 
used a stream of N2 gas to dry solvents, and a gravitational column to carry out SPE.  
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The cost to carry out these 3 methods was not calculated, but, it would be assumed that 
Method 3 would be the most expensive to carry out because it uses the most chemicals. 
However, the cost of a method should not impact a decision on what method to use if 
it produces better results.  
 
The most important consideration of a methods is the results which the method 
produces. It is important that the method has repeatable accuracy, precision and 
robustness; if not, then the method is not useable. In preliminary milk sample extracts, 
Method 1 HPLC-DAD chromatograms were more repeatable compared with the other 
methods. HPLC chromatograms of milk sample extracts using Method 1 also had a 
lower sound to noise ratio after tR = 13 min. This is important because endogenous 
estrogens and xenoestrogens are eluted after 13 min using the study’s HPLC method. 
If there was high noise at the same time as a compound eluted, this can lead to an over 
estimation of a compounds concentration due to a broad peak, or the compound could 
be completely missed; therefore, leading to discrepancies. 
 
Method 1 was chosen for the study to carry out the extraction of endogenous estrogens 
and xenoestrogens from New Zealand cow’s milk because it can extract these 
compounds, it is quick and easy to carry out, and the results are repeatable with low 
noise in HPLC chromatograms where the compounds are known to elute. 
 
4.1.2 Validation of Selected Method 
 
For the extraction of endogenous estrogens and xenoestrogens, Method 1 was selected 
because of its ability to extract a broad range of estrogens and estrogen mimics, speed 
of extraction, and reliability.  
 
The first step of Method 1 was to remove any unwanted proteins in the milk, minimising 
the matrix effects. If the protein is not removed from milk it can lead to contamination, 
blockages and damage/adsorption to the stationary phases of chromatography columns. 
In Method 1, precipitation of the protein was achieved by the addition of acetonitrile, 
followed by centrifugation. This caused three layers to appear with the proteins forming 
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a solid precipitate layer in the centrifuge tube. The layer containing the residues of 
interest was the top layer; this was transferred to a new centrifuge tube for the clean-up 
step. Recently, a novel method was developed for the extraction of estrogens from milk 
samples using a nanocomposite of polypyrrole-coated nanoparticles (a nanoscale 
particle), removing the requirement for deproteination.216 This is because the 
polypyrrole coating has a highly p-conjugated structure and is hydrophobic. This 
attracts and captures the endogenous estrogens from milk samples. The method had 
very low limits of detection (5.1 x 10-6 – 6.6 x 10-5 mg/L) with LC-MS and high 
recoveries (83.4% – 108.5%) of endogenous estrogens.216 However to make these 
particles, they require synthetic chemistry. A solvothermal process is used, in which 
the precursors are mixed in a Teflon-lined stainless steel autoclave which is heated and 
then allowed to cool.216 If these particles could be adapted to extract other 
xenoestrogens, it could be a very useful method to use because it is quick to carry out, 
and produced low detection limits and good recoveries. 
 
Following deproteination, the analytes require further cleaning up by removing any 
remaining peptides, trace metals and other milk components which may still be present 
in samples. This is achieved either by liquid-liquid extraction (LLE) or SPE. In all of 
the selected methods, SPE was used. SPE is preferred over LLE because it is quicker, 
cheaper and easier to carry out. The reason that LLE is slower and more difficult to 
carry out is because of the larger amount of solvent required compared to SPE. The less 
solvent required for SPE leads to higher recoveries due to more of the matrix 
interferences retaining on the stationary phase instead of overloading the column and 
passing through.208, 218, 237 SPE is quicker due to smaller amounts of solvent is required; 
therefore, drying down extracts is faster. The most common stationary phase used for 
SPE is Oasis HLB sorbents. These have become the standard for methods developed 
for the extraction of endogenous estrogens and xenoestrogens from food matrices (e.g. 
milk, breast milk, honey, cheese) because of their effectiveness.14, 207, 208, 215, 222, 238, 239 
 
An important feature of the selected extraction method was the reproducibility of low 
noise in HPLC chromatographs. These had low noise between the tR of 13 – 29 min. It 
was important that this time period was clear because endogenous estrogens and 
xenoestrogens had retention times between 15 min – 28 min. The step of the method 
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responsible for this low sound to noise ratio in chromatographs was the clean-up 
component. This removed any matrix interferences that were left after the 
deproteination step. Removing the matrix interferences means the background noise is 
kept low allowing the low levels of endogenous estrogens and xenoestrogens to be 
detected and measured accurately.  
 
The evaluation of Method 1 indicates that it was the best choice for the extraction of 
endogenous estrogens and xenoestrogens from cow’s milk samples. Importantly, this 
method extracted xenoestrogens from cow’s milk in the study. As the name of the 
method suggests, it is quick, easy, cheap, effective, rugged, and safe. This was the 
quickest method to carry out with no difficult steps to carry out. The method was 
effective and rugged because the HPLC chromatograph consistently had low noise, and 
successfully extracted endogenous estrogens and xenoestrogens from spiked milk 
samples. This method was successful in producing low noise HPLC chromatograms in 
both full fat and skim milk showing that it is not limited to low fat samples. All 
compounds have clear separation with sharp peaks with HPLC-DAD analysis.   
 
Recovery of Target Compounds 
 
An indication of how well an extraction method performs is by recovery of authentic 
standards from spiked milk samples. The recoveries for this study are shown in in 
Section 3.6 (Table 3.5). The study produced a large range of recoveries for the target 
compounds; BPA had the lowest recovery of 61. 96 ± 7.81%, whereas the recovery of 
EE2 was 94.29 ± 12.38%. Overall the recoveries were split into two groups: compounds 
with recoveries not close to 100% and compounds close to 100%. The compounds that 
had recoveries not close to 100% were E2 (67%) daidzein (72%) and BPA (62 %). The 
compounds that had recoveries close to 100% were EE2 (94%), formononetin (84%), 
genistein (91%), equol (79%), and zearalenone (88%). Even though this method 
produced mixed recoveries for the target compounds, they are in line with published 
literature using methods which have been accepted for milk sample analysis.12, 158, 213, 
214, 217, 222 One exception in the stud was BPA; these study’s report recoveries 20% 
higher than the study. However, in one published study that is accepted for milk sample 
analysis had reported recovers below 80%.12 The authors stated that these recoveries 
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were acceptable because it was a  multiresidue method. They further stated that because 
the values were in the range of -50% – 20% for the minimum trueness of quantitative 
methods according to the EU commission decision 2002/657 that they were 
acceptable.12, 240   
 
The aim of this study was to assess the risk of milk in an estrogen mimic context; 
therefore, recoveries were corrected for when calculating the concentration of 
compounds in extracted milk samples. Some of the recoveries of the study were below 
75% which can introduce skepticism because large errors are likely when correcting 
for recoveries. Whereas, when the recovery is close to 100%, there is more confidence 
in the corrected concentration because of the increased accuracy compared with low 
revoceries.241 However, the recoveries obtained in this study are within the analytical 
acceptable range by not exceeding ± 20% for each recovery standard inject, which is a 
requirement stated in the Health and Food Safety (SANTE) report.242 If more accurate 
recoveries are required, isotopically labeled compounds should be used. However, 
these compounds are expensive and hard to work with.241 For completeness of a method 
this is something should be carried out because it adds to the robustness and reliability 
of the extraction method.  
 
A possible reason for compounds having different recoveries is that the magnitude of 
matrix effects exhibited is different. It is possible that target compounds co-extract with 
other components of milk which limits the detection of target compounds through 
matrix suppression, therefore lowering the recoveries of target compounds.17, 214 
Although rare, target compounds can be enhanced with compounds which co-extract 
with target compounds.213 Therefore it is very important that the fat globules are broken 
down; if not, compounds will not be released from the fat globules leading to low 
recoveries.214 The selected method minimises matrix effects from proteins and fats 
through the de-proteination and clean-up steps carried out.  
 
LOD and LOQ 
 
It is frequently reported that xenoestrogens are biologically active at low 
concentrations; therefore, it is important that the LOD and LOQ concentrations are as 
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low as the analytical method allows.84, 96, 105, 114, 188, 243 Therefore, analytical techniques 
which provide high sensitivity are important (e.g. HPLC-DAD, LC-MS). The analytical 
method used in the study was HPLC-DAD rather than LC-MS because data analysis of 
HPLC-DAD is quicker (discussed in Section 4.1). The important measure for 
determining the presence of a compound in a sample is the LOD. This is the lowest 
analyte concentration reliably distinguishable from a blank and at which detection is 
practical.244 Whereas, the LOQ is the lowest concentration at which the analyte not only 
can be reliably detected but at which a predefined goal for bias and imprecision is met 
(e.g. defined UV spectrum).244 The LOD and LOQ for the compounds of interest of the 
study were determined by diluting authentic standard in HPLC grade MeOH. The 
LODs and LOQs are shown in Table 3.2.  
The compound which had the highest LOD was E2 with a concentration of 0.1 mg/L; 
the compound with the lowest LOD was daidzein at a concentration of 0.0025 mg/L. 
E2 also had the highest LOQ at a concentration of 1 mg/L; however, the compounds 
with the lowest LOQs were the phytoestrogens (i.e. formononetin, daidzein, equol) at 
a concentration of 0.05 mg/L.   
 
The LODs of phytoestrogen recorded in this study are similar to previously published 
data using methods accepted for milk analysis. 158, 213, 220 These methods used HPLC, 
as well as the more sensitive LC-MS.158, 213, 220 However, the study’s LODs for 
zearalenone, EE2, BPA and E2 are not close to previously published LODs.12, 14, 17, 21, 
22, 212, 214, 216, 217, 245 The published studies having LODs 1,000 to 10,000 lower high than 
reported in this study.12, 14, 17, 21, 22, 212, 214, 216, 217, 245 This is because LC-MS has much 
higher sensitivity compared with HPLC-DAD.  
Milk is known to always contain endogenous estrogens, with the maximum basal 
concentration of these reported to be 3.3 x 10-5 mg/L.208, 212 Cow’s produce milk for 
their offspring which endogenous estrogens are important for the calves development; 
therefore, they will be present in the mother’s milk.208, 212 Therefore the analytical 
instrument used in the study was not sensitive enough to detect these low levels. The 
most suitable analytical instrument to detect the basal endogenous estrogen 
concentrations is LC-MS. The analytical method of this study could easily be adapted 




The director general responsible for the National Chemical Contaminants’ Programme 
(NCCP) will often publish reports on milk and dairy products. The information in these 
reports will be provided by ESR who monitor milk and dairy products. “The NCCP 
was introduced to confirm that the control of chemical residues in milk and dairy 
products is appropriate and effective. It ensures the safety, wholesomeness, and the 
truth of labelling of milk and dairy products for both domestic and export markets.”246 
Table 4.2 shows the residues which are monitored by this program.246 In these reports 
an action limit is quoted, which is “the lowest allowable limit applied by New Zealand, 
Codex, and destination markets.”246 Another measure that is often quoted in these 
reports is the Limit of Reporting, which is “the lowest level at which residues will be 
reported as absolute numbers. It is equal to and higher than the LOQ.”246 Very rarely 
do these reports quote a LOD for method used; therefore, it is possible that compounds 
might be present but at a concentration below the action limit or Limit of Reporting. 
This is concerning because compounds might be present, but the population would not 
be told because it is below these limits. This could give a false sense of security to the 
population as many would assume that if it is below the Limit of Reporting, that the 
compound is not there at all, which might not be the case.  
 
Phytoestrogens and some endogenous estrogens are not included on the list of residues 
that are monitored under the NCCP. The reason for this is because they are naturally 
present in pasture and the cow; therefore, the concentrations in milk are extremely hard 
to control. It is unreasonable to expect farmers to be able to control the amount of clover 
in pasture, and it would be almost impossible for the farmer to control the 
concentrations of endogenous estrogens in cow’s milk. The NCCP understands this and 
therefore do not monitor them.  
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Table 4.2: The residues that are monitored under the NCCP 
Registered agricultural compounds and 
veterinary medicines 
Unregistered or prohibited agricultural 
compounds and veterinary medicines 
Radionuclides Organochlorines 
Organophosphates Dioxin and dioxin-like PCBs 
Mycotoxins Potentially toxic elements 
Migration chemicals from food contact 
materials including packaging 
Maintenance compounds 
Possible adulterants 
Any other chemical of national or 
international interest. 
Any chemical compound or its metabolite that, via risk assessment or profiling, is 
considered to have the potential to adversely affect dairy material or product 
 
 
Although these compounds are hard to control, they should still be monitored; the 
endogenous estrogens in particular. The reason for this is because these compounds 
might have an effect on a consumer’s circulating estrogen levels; for example, if milk 
has a high concentration of E1, this can be converted to E2. Thus, increasing the 
concentration of estrogens in circulation. The circulating concentration of estrogens are 
tightly regulated in the body because of their tight activity ranges; therefore, if 
endogenous estrogens are consumed and absorbed, the circulating estrogen 
concentration might increase. An increase in the circulating estrogen concentration 
could lead to an increase in the risk of breast cancer or decrease in sperm count. The 
reason for this could be because of the increased circulating estrogen concentration 
leads to an increased binding to ERs, and therefore, the responses elicited.  
 
The mechanism of phytoestrogen estrogenicity is not well understood, which might be 
a reason why the NCCP does not monitor their concentrations. It is also possible that 
the ADIs for phytoestrogens might be high; therefore, the NCCP will not monitor them. 
It is possible that the ADI for a phytoestrogen might be so high that the cow would die 
in order to obtain the concentration in milk. As mentioned in Section 1.6.2, the ADIs 
for phytoestrogens are likely set high because the endpoint of the NOAEL toxicity 
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experiment might be a change in an enzyme concentration rather than a hormonal 
change. This would cause a big difference in NOAEL concentration because smaller 
concentrations are required to cause a hormonal change.   
 
4.2 Assessment of the Concentration of Xenoestrogens in New Zealand 
Cow’s Milk 
 
To the best of our knowledge, this study is the first time that genistein, daidzein and 
BPA have been identified in New Zealand cow’s milk sample extracts. These 
compounds were identified using a quick, easy, cheap and rugged method. In milk 
samples (n = 30) BPA was detected in 30% (9/30), daidzein was detected in 3.3% 
(1/30), and genistein was detected in 3.3% (1/30). The identification of these 
compounds was confirmed by co-chromatography with authentic standards and 
copying UV spectra using DAD. As previously discussed (Section 4.1.2) 
concentrations were corrected for recoveries to give a better estimate of actual milk 
concentrations to assess the risk of milk an estrogen mimic context. In this study, 
genistein was identified at a concentration of 0.062 mg/L after the treatment of 
sulfatase/b-glucuronidase enzyme from H. pomatia. Therefore, genistein was present 
in milk in a conjugated form; incubation with this enzyme broke this bond, releasing 
the aglycone. This is interesting because if genistein is present in its conjugated form 
in milk, when humans drink this milk, the gut microbiota could release the aglycone. 
This could then be absorbed into the blood stream where is could bind to ERs. Whereas, 
if genistein was present as the aglycone in milk, it would likely be conjugated by 
enzymes in the human gut and directed for excretion. Therefore, xenoestrogens present 
in their conjugated form in milk could be more concerning than when they are 
unconjugated.  
 
This study is unlikely to be a true reflection of New Zealand cow’s milk as a whole. It 
is more likely to show a local picture (i.e. Christchurch/South Island). The reason for 
this is because of milk pooling. Most dairy farms belong to a dairy co-operative (e.g. 
Fronterra) to give farms more power to demand better prices in the market. All farms 
part of the co-operative will send their milk to center owned by the co-operative. Here 
all of the individual farm’s milk will be pooled together and mixed. The purpose of this 
 107 
is to dilute any compounds with high concentrations and to make all the milk equal. 
This is not just to dilute unwanted compounds, but to make sure the nutritional value is 
also the same. These pooling centers are all over the country; for example, one in 
Christchurch, one in Auckland etc. Therefore, milk purchased in Auckland might be 
different to milk purchased in Christchurch. The pooling of milk is very good because 
it should balance and dilute any high concentrations of compounds, decreasing the risk 
to the consumer.  
 
Milk sampling in this study was carried out by purchasing milk from local supermarkets 
in the Christchurch city region on different days. Expiry dates of milk were confirmed 
to be different to ensure they were from different batches. This study’s sample size was 
small (n = 30) because this was a pilot study to evaluate if further monitoring is 
required. As mentioned previously, this study is likely to provide a snapshot of cow’s 
milk from the South Island. To assess New Zealand cow’s milk in its entirety, a larger 
sample size is required; for example, the number of samples should be above 100, with 
samples purchased from different cities in New Zealand throughout the whole year. 
This would provide the most complete picture of the state of New Zealand milk 
containing estrogen mimics. However, this study’s findings provide a preliminary 
insight into the presence of endogenous estrogens and estrogen mimics in cow’s milk. 
This could be extrapolated to milk across the country being as climate, regulations, and 
farming practices are likely to be the same. Any differences there might be is unlikely 
to cause a large variation to the findings in this study. The only event which could cause 
a difference would be if there was a natural disaster (e.g. earthquake, tsunami, flash 
flooding) which would lead to a cow being treated differently to affect its milk.  
 




Phytoestrogens were found in 2 out of 30 (7 %) cow’s milk sample extracts from 
Christchurch. Genistein was found in one milk sample extract after the treatment of 
sulfatase/b-glucuronidase enzyme from H. pomatia at a concentration of 0.062 mg/L. 
Daidzein was identified in one milk sample extract at a concentration of 0.026 mg/L. 
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The presence of phytoestrogens was not consistent, and the concentrations were low. 
This was surprising because the major food source of New Zealand dairy cows is 
pasture, which contains red and white clover. Both of these species of clover are known 
to contain phytoestrogens.155, 156 The most persistent clover species in New Zealand 
pasture is white clover because it is the most suited to the climate and growing 
conditions which are provided.247 The major phytoestrogens in white closer are 
formononetin, biochanin A, genistein, and daidzein.155 Therefore, New Zealand cows 
will consume these phytoestrogens from pasture; this could be transferred into the 
cow’s milk. Other exposure routes for cows to phytoestrogens include soy-based feeds 
which are offered by famers throughout the year as an alternative to pasture. These 
feeds could be the major food source in the middle of seasons; for example, in winter 
because pasture is frosty and waterlogged, and summer when conditions are very dry, 
and pasture is dead. However, this is not the only alternative to pasture; farmers will 
choose the supplementation based upon the cheapest form of energy. Farmers might 
choose soy-based pellets because it can make lactating cows peak earlier with greater 
milk yields when it is included in the diet. These pellets will include phytoestrogens 
because they are made from soy, most commonly genistein, daidzein and glycitein; 
however, these are likely to be conjugated to glucose producing the respective 
glucoside compounds genistin, daidzin, and glycitin.248 Once these glycosides reach the 
gut of cows, the glycosidic bond is broken by the microbiota, releasing the ‘free’ 
compounds where they can then be absorbed or metabolised.248  
 
The compounds get into milk by crossing the blood-milk barrier which is likely 
analogous to the blood brain barrier; a highly selective semipermeable membrane 
barrier that separates the circulating blood. Interestingly, phytoestrogens have been 
shown to induce cell death of these membrane components.249 This could cause the 
milk to mix with blood components, which could increase the risk of these components 
(e.g. phytoestrogens) getting into milk.249 If this is the case, and phytoestrogens cross 
the barrier, it would be expected that phytoestrogens would be present in milk. In New 
Zealand, this concentration might be high because of the concentration of clover species 





Metabolism of Phytoestrogens 
 
As alluded to previously, phytoestrogens are extensively metabolised by the microbiota 
of cows.20, 155  These compounds are chemically altered by the addition of hydroxyl 
groups which, In turn, changes the compounds ability to be absorbed. The metabolism 
of phytoestrogens in cows was investigated by setting up a model rumen system. Cow 
rumen slices were collected from Silver Fern farms and incubated in Wilkins Chalgren 
broth spiked with formononetin (10 mg/L). The broth was extracted daily for 3 days. 
In this system, formononetin was suspected to be metablised to equol. This peak had 
the same tR and UV spectrum as an equol authentic standard. The identity of the 
suspected equol peak was confirmed by spiking extracts with authentic standard. This 
caused an increased response of the peak when analysed by HPLC-DAD. This 
confirmed that the identity of the peak was equol. This finding indicated that the system 
is able to produce metabolites of phytoestrogens.  
 
The results of the incubation of formononetin with cow rumen slices in the context of 
the risk milk has in an estrogen mimic context is interesting. As previously mentioned, 
equol is more estrogenic than its precursors (i.e. daidzein, formononetin, o-methyl 
equol).158 Therefore, the study showing that equol is produced in the rumen is 
interesting because it means that compounds in pasture (e.g. formononetin) can be made 
more estrogenic; if equol can be transferred to milk, it would likely increase the 
estrogenic load. However, this study did not identify equol in New Zealand cow’s milk 
sample extracts, which was surprising. It is possible that equol is not transferred across 
the blood-milk barrier; however, other published studies have identified equol in cow’s 
milk extracts. It was also surprising that daidzein, another common phytoestrogen 
metabolite was not produced in the cow gut model. This was a surprise because 
daidzein is an intermediate to the production of equol; however, it is possible that the 
major route of metabolism to equol is via o-methyl equol instead of daidzein.155, 157-160, 
250 It is possible that the bacteria which carry out this conversion  are not present in the 
samples. In the cow gut, bacteria are distributed differently to aid in digestion; for 
example, the bacteria on the rumen wall are likely to be different to the bacteria in the 
rumen liquid.251  Different species of bacteria are likely to metabolise compounds 
differently or carry out different parts of metabolism. The different distribution of 
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bacteria makes assessing the system difficult as it is likely the only a snapshot of the 
bacteria is present in the complete system. 
 
To the best of our knowledge, this is the first time that rumen slices have been used to 
show the cow’s metabolism. Typically, rumen liquid is removed from cannulated dairy 
cows to show metabolism.159, 250, 252 One possible difference between these systems are 
the bacteria present. The different distribution of bacteria makes assessing these 
systems difficult as it is likely the only a snapshot of bacteria is present in both system. 
The rumen is a complex system and investigation into cow gut metabolism needs to be 
continues. A more realistic system of the cow gut would be to combine the rumen liquid 
and rumen slices together.  
 
The cow rumen samples used in the study were supplied by Silver Fern Farms, a 
livestock processing and marketing company. For this reason, livestock are completely 
cleaned by flushing the carcass with water. It is likely that bacteria which are loosely 
attached to the rumen wall are dislodged and washed out in this cleaning 
process. Therefore, it is possible that this system is not a complete representation of a 
cow gut. These samples were also exposed to an aerobic environment, which could 
cause some bacteria to die. The reason for this is that the gut is likely to be slightly 
anaerobic; therefore, the regular metabolism by the microbiome might not be carried 
out as not all of the microbiome is present in this system. It would be interesting to 
obtain cow rumen samples before the washing procedure to see if there are any 
differences in metabolite production between washed samples and unwashed samples. 
However, for an initial study into the metabolism of phytoestrogens in the cow gut, this 
is a good representation. Typically, researchers will use cell lines/models instead of live 
tissue samples to investigate metabolism; for example, the Caco-2 cell line from human 
small intestine which has been used to investigate drug metabolism.253 Both systems 
have their benefits; live tissue is likely the best as it is closer to the real situation; 
however, it can be hard to access (e.g. human tissue). Whereas, cell lines may not be as 
close to the real situation as live tissue, but they are a good model for prediction and a 




Modification of compounds is not the only route of metabolism. Another route of 
metabolism is through the addition of sulfate groups and glucuronides. The addition of 
these groups increases the compounds water solubility so that they can be absorbed in 
the blood stream and directed for excretion. Genistein was identified in New Zealand 
cow’s milk after deconjugation by the sulfatase/b-glucuronidase enzyme from H. 
pomatia, which is consistent with published literature.20, 157, 220 Thus, when genistein is 
consumed from the pasture, it is metabolised by conjugation in the cow’s gut. Genistein 
can also be formed in the rumen of cows by the microbiota metabolising biochanin A 
from clover to genistein. Genistein is then bound to a glucuronide group or sulfate 
group, making the compound more soluble for excretion, or as demonstrated in this 
study, directed to the milk by crossing the blood-milk barrier.12   
 
When humans consume milk containing phytoestrogen conjugates, the compound-
conjugate bond is likely to be broken. The enzyme in the human gut capable of this is 
sulfatase and b-glucuronidase depending on the conjugate; thus, releasing the un-
conjugated compound.254 These compounds can be further metabolised by the gut 
microbiota or absorbed in to the blood stream. Interestingly, more than double of the 
non-conjugated compound is absorbed compared with the conjugated forms.254 
Therefore, it is possible that a dose of conjugates leads to a higher estrogenic load 




The findings of this study show the presence of BPA in New Zealand cow’s milk 
samples. The concentrations measured in this study are low (0.012 – 0.066 mg/L) and 
of little relevance in an endocrine disruption context; however, it will likely be part of 
a cocktail. It is possible that BPA and other xenoestrogens will be additive because they 
have structural analogies with one another. BPA is capable of binding to ERs, as are 
other xenoestrogens; therefore, it is likely that they will have a sum of effects of the 
individual compounds. For this reason, it is important that residue concentrations are 
kept as low as possible. The source of BPA in cow’s milk is likely to be coming from 
one of two sources. These two sources are either the production process of milk (e.g. 
milking equipment) or, from the packaging milk is sold in (e.g. milk bottles, milk 
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cartons). This study did not consistently identify BPA in milk sample extracts being 
identified in 9 of 30 (30%) milk sample extracts. If the source of this contamination 
was coming from either of these sources, a consistent appearance of BPA would be 
expected; however, as previously mentioned, New Zealand milk is pooled and mixed. 
Thus, any high concentrations of compounds are diluted during this process. Leaching 
of BPA from plastic equipment in farming equipment might be expected be consistent 
because equipment is only replaced when broken. Therefore, once the equipment 
started to leach BPA, it is likely to continue. However, BPA might only leach from new 
products for a short period of time. Whereas, leaching from milk packaging is likely to 
be more variable. For BPA to leach from plastic bottles it needs to be heated up. Milk 
is usually left in a fridge, otherwise it quickly goes off; therefore, leaching from bottles 
is unlikely.   
 
Cows are milked using specialised equipment. This consists of a rubber lined teat cup 
which is attached to the cow’s teat (Fig. 4.1). The teat cup creates a vacuum to mimic 
a calf suckling. A vacuum is important otherwise the cow will stop releasing milk. The 
milk travels from the teat cup through rubber tubing into a claw bowl. This is 
transparent and tough being made of industrial grade plastic (Fig 4.1). It is important 
that the claw is see-through so that farmers can see any issues with the milk (e.g. the 
presence of blood). It is also important that the claw bowl is tough because of the rough 
environment it is in. From the claw bowl, milk travels through rubber or silicone tubing 
into stainless-steel piping (Fig. 4.1). From the stainless-steel piping, milk enters a 
receiver can. Milk is then filtered and taken to stainless-steel bulk tanks (silos; Fig. 4.1). 
Milk is stored here until it was collected by milk tankers to take it to pooling centers. 
Of the milking equipment mentioned above, the claw bowl is the only the piece of 
equipment possibly made of materials containing BPA. It also comes in direct contact 
with milk, giving opportunity to leach BPA. However, if the claw was the source, BPA 
might be present in all milk, even with milk pooling. This would likely be the case 
because all claw bowls should be made from similar plastics, despite manufacturer. 
However, it is most likely that this leaching will only be from new products. When 
plastics are synthesised with BPA monomers, 100% efficiency is unlikely; therefore, 
there will be ‘free’ BPA monomers which will leach into liquid for a period of time. 
Once all the ‘free’ BPA has gone, this product will stop leaching BPA, unless more is 
released (e.g. from heating up the plastic). This could explain the inconsistent presence 
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of BPA in cow’s milk. The type of plastic used to make claw bowls was investigated 
by contacting Skellerup (a New Zealand dairy milk equipment supplier). A Skellerup 
employee was contacted 4 times regarding this. Unfortunately, this study’s enquiry was 
passed onto the technical manager, who did not respond; and the general manage, who 
also did not respond. It is possible that Skellerup did not want to be interrogated about 
their products containing BPA or possible negative publicity associated with their 
products. Not receiving an email from the general manager or technical manager 
regarding the composition of their products indicated they do not want to be involved.  
 
Figure 4.1: Specialised farming equipment found on a dairy farm. The rubber lined teat 
cup (top left) is attached to the cow’s teat with a vacuum applied to mimic a 
suckling calf. The milk flows through the rubber tubing into a plastic claw bowl 
(top left). From here it flows though rubber or silicone tubing into stainless steel 
tubing and collected in a receiver tank (top right) before being filtered (bottom 
left) and stored in silos (bottom right) for collection by milk tankers.  
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The other possible source of the BPA in milk sample extracts is from the plastic bottles 
or cartons that milk is packaged in (Fig 4.2). Milk bottles and their lids are a soft semi 
opaque plastic which might use BPA monomers in the synthesis. Meadow Fresh (a New 
Zealand milk company) were contacted to ask the composition of their milk bottles. 
After a few emails, they stated that their bottles were ‘made of food grade HDPE 
plastic’ (Fig. 4.2). HDPE is a polyethylene thermoplastic made from petroleum, thus, 
BPA is not used in synthesis of the plastic milk bottles. Meadow Fresh were also 
questioned about the making of paper milk cartons. Milk cartons are a paper like 
product which is laminated so that the milk does not leak from the carton (Fig. 4.2). 
Meadow Fresh were a little more apprehensive to release this information; however, 
they confirmed that milk cartons are made of paperboard from wood chips, which has 
a waterproof layer applied, typically polyethylene. Therefore, based on the information 
Meadow Fresh provided about the composition of the plastic milk bottles and the 
paperboard cartons, BPA is highly unlikely to be coming from the packaging. The only 
other possibility is the seal which is underneath the cap (Fig. 4.2). This confirms that 
the milk has not been tampered with. There is the possibility that the plastic on the 
underside of the seal has a coating which uses BPA in the synthesis; this is very unlikely 











Figure 4.2: Packaging which cow’s milk is sold in. Milk cartons (1) are made of 
paperboard with a PE coating on the inside, whereas milk bottles (2) are made of 
HDPE, which does not contain BPA, however, the seal on new milk bottles (3) 
may have a coating (4) of BPA which is leaching in to cow’s milk.   
 
2 3 4 1 
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It is possible that the BPA is not in the milk and instead is a contamination from lab 
equipment. It was well understood that BPA would be a contamination issue before 
starting milk sample extractions; therefore, extreme caution was taken to use as little 
plastic products as possible. In the early stages of milk sample extractions, single use 
sterile syringes were being used. When these extracts were analysed by HPLC-DAD a 
peak appeared in the same region as BPA. For this reason, it was decided to switch to 
glass syringes; when glass syringes were used instead, this peak disappeared. It was 
thought that the coating on the inside the of plastic sterile syringes was leaching into 
milk sample extracts, contaminating the sample. The only plastic product used which 
could not be avoided were 50 mL PP centrifuge tubes. No other members of the lab 
group had previously reported issues with BPA contamination using these centrifuge 
tubes; therefore, it was decided that they could be used and would not leach BPA. If 
BPA was a contamination of the lab, it would be present in every milk sample extract; 
however, it was only identified in 9 samples. Therefore, BPA was actually present in 




Extracted milk samples analysed by HPLC-DAD often produced a peak with a tR of 
13.5 min. This peak had a UV spectrum similar to equol with slightly shifted adsorption 
maximum and eluted earlier than equol. It was suspected that this was a equol 
metabolite.  
Unfortunately, no purchased authentic standards had the same retention time of this 
compound; therefore, the peak was investigated. Firstly, the peak was fraction collected 
using the HPLC-DAD set up. The residue was then analysed by direct inject probe mass 
spectrometry which identified an ion of 349.1263 m/z. The residue was also subjected 
to NMR to elucidate more information about the unknown peak. Unfortunately, the 
residue concentration was too low, and only solvent peaks were observed. The identity 
of the peak was hypothesized based on common metabolism pathways; for example, 
addition of hydroxyl groups, ring opening, addition of a sulfate or glucuronide.250, 255 
The addition of a glucuronide to equol lead to a mass which was too high for the mass 
spectrometry results, therefore it could not be a glucuronide metabolite. However, the 
addition of a sulfate group to equol lead to a mass of 322.33 (Fig. 4.3), which is close 
to the mass spectrometry result. Ring opening, with the addition of one and two 
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hydroxyl groups lead to masses of 340.35, 335.33, and 354.33 respectively (Fig. 4.3).  
Unfortunately, the correct mass could not be hypothesised for the residue. It is possible 
that this peak is not a metabolite of equol; instead it is an unrelated component of milk 
which has a similar UV spectrum to equol and a similar retention time as phytoestrogen 
metabolites.  
 










Figure 4.3: Hypothesised structures of potential equol metabolites. An unidentifiable 
peak (tR = 13.540) in HPLC-DAD was fraction collected and subjected to direct 
inject probe mass spectrometry. The unidentified metabolite has an ion mass of 
349.126 m/z. None of the above hypothesised structures have the same m/z.        
 
4.3 Concentration of Endogenous Estrogens and Xenoestrogens Across 
the World 
 
An extensive literature search was carried out using Google Scholar, Web of Science, 
Scifinder, and Scopus using the key words; milk, estrogens, endocrine disruptors and 
liquid chromatography, dated from 1990 onwards to find all the data on measured 
concentrations of endogenous estrogens and xenoestrogens in cow’s milk. From the 
references that were generated, these were further narrowed down based on 4 selection 
criteria: the concentration from milk samples; analytical results provided; recoveries 
above 70%; and internal standards used. 21 references met all selection criteria. Milk 
is produced and consumed in large quantities around the world; therefore, it was 






























of milk containing a high estrogenic load. Governments will closely monitor milk; 
however, it is unlikely that they monitor for phytoestrogens (discussed in Section 4.1.2) 
or publish these studies. As previously discussed, ADIs for phytoestrogens will likely 
be high because the toxicity data used for these are unlikely to be based on a hormonal 
change. Regulators will understand that estrogenic compounds work at concentrations 
lower than the action limits; however, they choose to ignore this because they see it as 
an acceptable risk. They are likely to be more concerned that the nutritional content is 
correct, as well as making sure that banned or highly regulated substances are not 
present in the milk. The reason for this is because milk cannot be exported if banned 
and highly regulated substances are present, or the nutritional value is not true to label. 
From the 21 references that met the selection criteria, concentrations of endogenous 
estrogens and xenoestrogens in cows varied depending on where in the world the milk 




The concentration of phytoestrogens (formononetin, equol, daidzein, genistein) appear 
to be higher in European countries compared with USA and China. A possible reason 
for this is that farming methods differ between Europe, and, USA and China. The 
differences may also be due to the difference in climate (e.g. rainfall). It is likely that 
all of these countries have different rainfalls throughout the year, with Europe likely to 
be the most consistent through the year, whereas, warmer temperatures would be 
expected in China and USA. This will affect when cows are able to graze pasture, and 
therefore, milk production. Farmers commonly supplement the cows diet with soy feed, 
silage, hay, and concentrate (carbohydrates, proteins, fats, minerals) to maintain the 
cow’s nutritional requirements. Silage and soy feeds can be particularly high in 
phytoestrogens which could explain the high concentrations in Europe. The climates of 
USA and China in addition to the composition of pasture in these countries means that 
cows have a smaller exposure to xenoestrogens; this leads to lower concentrations of 
phytoestrogens in milk. However, the drier climates of USA and China may mean that 
in summers, farmers require supplementing feed in summer which would possibly 
increase the concentration of phytoestrogens in cow’s milk. 
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The literature search identified that cow’s milk produced in Australia contained very 
high concentrations of equol compared with other countries.157 The source of the high 
concentrations of equol is likely to be from high exposures of formononetin and 
daidzein in their diet. The source of the high concentrations of these compounds are 
likely from red and white clover that is present in the pasture.156-158 As previously 
mentioned (Section 1.6.1), bacteria in the cow’s rumen can convert formononetin to 
equol via daidzein, which is likely reason for the presence of equol in Australian cow’s 
milk.158 Once equol has been produced, it might be conjugated via sulfation or 
glucuronidation and absorbed into blood. From here it can be transported and released 
into the cow’s milk.155, 157-160 It should be considered that it will not only be equol that 
will be present in its conjugated form; other phytoestrogens are likely to be absorbed 
from the cow’s gut in their conjugated forms where they might be transferred to milk.157 
If phytoestrogens are present in cow’s milk in their conjugated forms, humans would 
consume them. Once in the human gut, they might be deconjugated and absorbed.254 If 
this occurs, this could be of concern because equol has a higher estrogenicity than its 
parent compounds (formononetin and daidzein).158, 159 Therefore, equol could bind to 
ERs and illicit a response; for example, the upregulation of genes responsible for E2 
synthesis. Whereas, if phytoestrogens are present in milk in their unconjugated form, 
then in the human gut they are likely to be metabolised by conjugation, where they are 
then directed for excretion. This removes the possibility that they could cause an 
estrogenic effect.  
 
4.3.2 Endogenous estrogens 
 
Endogenous estrogens in cow’s milk follow a similar trend to phytoestrogens as 
discussed in section 4.3.1. Concentrations of endogenous estrogens are higher in 
Europe than the rest of the world, based on the findings of the literature review. The 
concentration of endogenous estrogens will depend on which trimester the cow is 
milked in.12 It has been shown that when cows are milked in the final trimester, the total 
concentration of estrogens present in milk is three times higher than milk from the first 
trimester.12 Unfortunately, this cannot be avoided; however, this could be taken into 
consideration by the farmer by not using milk from the final trimester when endogenous 
estrogen concentrations are at their highest. However, this is not a feasible option for a 
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farmer because the whole heard is likely to be in the same stage of lactation. This would 
cause the farmer to lose a large source of their income. One possible option is to split 
the heard into two, and offsetting when each heard would be in trimester 1 and 3. This 
would allow for mixing third trimester milk with first trimester milk to dilute the 
concentration of the endogenous estrogens in trimester 3 milk. In New Zealand, this is 
overcome by pooling milk, which dilutes milk from trimester 3.  
 
4.3.3 Other estrogen mimics 
 
Only 5 published literature met the requirements which were set that investigated other 
estrogen mimics (i.e. BPA, NP, zearalenone). The findings indicated that BPA can be 
present at high concentrations. In a study carried out in Italian cow’s milk, BPA was 
found at a concentration of 0.5 mg/L. However, in China concentrations were measured 
at 4.90 x 10-4 mg/L. This difference could be down to the farming equipment used to 
milk cows or the milk bottles (Discussed in Section 4.2.1). It is possible that milk bottles 
in Italy at the time still contained BPA, which might lead to high concentrations in 
cow’s milk. It is also concerning that there appears to be little research on the presence 
of mycotoxins in milk; only 1 research article was found to meet the set requirements 
of the literature review. The research article reported concentrations of zearalenone 
with a big range; it reported concentrations from 0.01 x 10-4 mg/L to 205 x 10-4 mg/L. 
Zearalenone is likely to enter milk by cows eating crops growing or stored in warm, 
humid climates contaminated with Fusarium fungi. The high concentration reported in 
milk might show the effect of cow’s eating poorly stored, contaminated crops. The 
reason for the lack of data on mycotoxins in cow’s milk might be because they are not 
commonly present in milk. The Fusarium fungi only grow in warm moist climates; 
therefore, these fungi might not thrive in many of the countries where mycotoxins have 
been investigated. 
 
An interesting observation from the literature review was that as the fat content of milk 
increases (skim milk vs. whole milk), the concentration of xenoestrogens present was 
increased. This is likely because endogenous estrogens and xenoestrogens are fat 
soluble, therefore as the fat content of milk increased, more xenoestrogens can be 
present in the fat.245 For example E2 in skim milk from Spain was found at a 
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concentration of 11 x 10-4 mg/L; whereas, in whole milk, E2 was found at a 
concentration of 54 x 10-4 mg/L. This suggests that drinking higher fat content cow’s 
milk will mean a higher dose of endogenous estrogens and xenoestrogens is received; 
therefore, it may be a higher risk factor for breast cancer and decreased quality and 
quantity of sperm  
 
4.3.4 This Study’s Findings Compared with Data in the Scientific Literature 
 
Phytoestrogens and xenoestrogens found in milk sample extracts in this study were 
similar to the concentrations of published data. This study identified the presence of 
genistein and daidzein in New Zealand cow’s milk extracts. The concentration of 
genistein (0.062 mg/L)  and daidzein (0.026 mg/L) was higher than the concentrations 
recorded in Australia (genistein = 0.022 mg/L), USA (genistein = 0.35 x 10-4 mg/L, 
daidzein = 0.24 x 10-4 mg/L), and Europe (genistein = 0.057 mg/L, daidzein = 0.016 
mg/L).19, 157, 213, 220 These concentrations are likely because of the high concentration of 
phytoestrogens that cows consume in their diet. Interestingly, this study did not identify 
equol, which was surprising. It would be expected that equol would be identified 
because of the high concentrations of phytoestrogens that New Zealand cows are 
expected to consume. New Zealand pasture contains high amounts of white clover that 
cows graze. This clover is known to contain the precursors of equol (daidzein, 
formononetin). Equol was identified in an Australian study at a high concentration 
(0.292 mg/L); this added to the surprise of not finding it in this study. It is likely that 
the species present in New Zealand pasture would be similar to Australia due to the 
similar conditions. The concentrations which genistein was found means it would be 
expected that equol would be present from the metabolism of genistein. It is possible 
that equol was present, but below the LOD for the analytical method. Formononetin 
was also not detected in this study. This is expected from literature, and the known 
metabolism routes. Formononetin is rapidly converted to equol by the cow rumen 
microbiota.155, 157-160  
 
BPA found in New Zealand cow’s milk extracts was found in 9 of 30 samples (30 %). 
The concentrations of BPA ranged from 0.012 mg/L to 0.066 mg/L. The concentrations 
measured in this study are similar to concentrations measured in Europe                          
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(9.9 x 10-4 – 0.5 mg/L) and China (4.9 x 10-4 mg/L); however, the concentration range 
in this study was more precise compared with Europe.21, 22, 214 A reason for this may be 
because in New Zealand the plastic milk bottles and cartons do not contain BPA and 
instead made of HDPE; whereas, in Europe at the time of the studies, BPA might of 
still been used as a monomer of the plastic. Therefore, it was possibly leaching into the 
cow’s milk. However, as discussed in Section 4.2.1, the current materials used for milk 
packaging means that this is unlikely to be the source of BPA in cow’s milk. Instead it 
appears more likely that equipment used during the milking and collection process are 
the source of contamination. The claw bowl is made of industrial grade plastic and 
possibly contains BPA. More investigation is required in to the milking equipment to 
locate where the BPA contaminating milk is from. 
 
New Zealand’s cow’s milk appears to be safer in an estrogen mimic context compared 
with published data from other countries measuring the concentration of endogenous 
estrogens and xenoestrogens. This study did not find endogenous estrogens, 
mycotoxins or EE2. This is an important finding because these are more estrogenic than 
phytoestrogens. Therefore, suggesting that the risk of New Zealand cow’s milk in an 
estrogen mimic context is lower compared with other countries. However, it is possible 
that these compounds are present, but are below the LODs for the method used in this 
study. This is almost certainly the case for endogenous estrogens which are reported to 
have a basal concentration of 3.3 x 10-5 mg/L.208, 212 Another important finding of this 
study is that the phytoestrogens and xenoestrogens that were found in New Zealand 
cow’s milk were not consistently present. This suggests that mixing milk from different 
farms is beneficial by diluting any unwanted compounds. Overall New Zealand milk 
appears to contain less endogenous estrogens and xenoestrogens compared with other 
countries based on this study.  
 
4.4  Glyphosate  
 
Glyphosate is the most used broad-spectrum herbicide in the world and is the active 
ingredient of Roundup. In New Zealand, farmers choose to seasonally spay Roundup 
on pasture to kill off remaining pasture and weeds so that new pasture can be planted. 
Whereas, in other countries, crops have been genetically modified to be resistant to 
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these herbicides. This allows farmers to spray their crops to kill off weeds without 
killing their crops. These crops are not allowed to be used in New Zealand because 
genetically modified crops cannot be grown here. The use of Roundup increases the 
efficiency of crops because they do not have to compete with weeds for important 
nutrients and space. Roundup require ~ 1 kg/hectare to be sprayed to kill unwanted 
wees; however, because New Zealand uses Roundup differently to the world, more 
glyphosate might be required to kill crops as well as weeds.256 With controversy 
sounding the use and effects of glyphosate-based herbicides, it is important to 
understanding its risk to the environment, consumers and farmers. 
 
All herbicides and pesticides have a withholding period which is the time between when 
a chemical is last used to when the food can be planted/harvested, or an animal can be 
slaughtered. This ensures the residue level does not exceed the ADI or other residues 
legislative parameters (e.g. MRL). Although this withholding period is in place it might 
be expected that residues are still present on food and in pasture. Recently, glyphosate 
residues were identified in ice cream from the United Kingdom at low concentrations 
(0.001 – 0.00123 mg/L), indicating that residues can be transferred from pastures to 
final prodct.117 In New Zealand, glyphosate is used extensively used in farming; the 
cattle are given glyphosate sprayed pasture to graze; therefore, it is possible that cows 
are consuming pasture containing glyphosate residues, which might be transferred to 
the milk and tissues. 
 
In 2015, the NCCP analysed milk samples for the presence of glyphosate residues. 
Here, it was reported that no glyphosate resides were found above the limit of reporting 
(0.05 mg/L).257 This reporting limit is 10-fold more higher than concentrations reported 
in ice cream from the United Kingdom. In this study the presence of glyphosate in 
cow’s milk was investigated using a high sensitivity method for the analysis. A method 
was used that had been previously accepted for the extraction and analysis of these 
residues in milk at concentrations as low as 0.001 mg/L.209 The method used LC-MS; 
the benefit of this LC method was that the specific column used separated components 
based on their charge. These columns can also separate on hydrophobicity (i.e. normal 
phase and reverse phase). Unfortunately, LC-MS did not produce a mass ion consistent 
with glyphosate when an authentic standard was injected; however, when the same 
authentic standard was analysed by direct probe injection mass spectrometry, a mass 
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ion consistent with glyphosate was produced. Therefore, the unusual step to use direct 
probe inject mass spectrometry for the analysis of cow’s milk was taken. This step was 
decided to be taken because when an authentic glyphosate standard at a concentration 
of 0.001mg/L was injected, a mass ion consistent with glyphosate was present. 
Therefore, it was decided that direct probe injection mass spectrometry was sensitive 
enough to detect the low levels which might be present in cow’s milk. It was not known 
why the column could not separate and produce a mass ion consistent with glyphosate; 
one possibility is that it might bind to the column and not be released.  
 
Five extracted cow’s milk samples were analysed by direct probe inject mass 
spectrometry. In these 5 sample, none contained a mass ion consistent with glyphosate. 
However, by not using LC it is possible that matrix effects lead to suppression of the 
low concentrations of glyphosate in the cow’s milk sample extracts, and therefore, no 
mass ion corresponding to glyphosate. LC would have been very beneficial as it would 
remove matrix effects by forcing glyphosate to loosely bind to the column and elute 
after the components which might suppress it. This is controlled by altering the 
composition of the mobile phase over time; which, in turn, causes compounds to elute 
due to their polarity. Using direct injection probe mass spectrometry means that an LOD 
or LOQ cannot be determined; therefore, one conclusion which can be drawn is that 
glyphosate is unlikely to be present in New Zealand cow’s milk. The analysis of 
glyphosate in food products is currently ‘trendy’ because the complete toxicity profile 
is not known. A possible reason for the toxicity profile not being known is because the 
mechanism of action of glyphosate is also not known. This is a critical piece of 
information to understand the toxicity of glyphosate.  
 
A possible mechanism of action of glyphosate is that it binds to ERs leading to a 
conformational change facilitating ER dimerization; which, in turn, could lead to an 
increase transcription of EREs. The ability of glyphosate to bind to ERa was 
investigated in-silico using Schrödinger Suite-Small-Molecule Drug Discovery Suite 
2017-1. Using X-ray crystal structure coordinates for human ERa, rigid docking of 
glyphosate in the LBC of ERa was performed using Glide in XP mode, and a docking 
score was produced. Docking score approximates the ligand binding free energy, which 
includes contributions such as electrostatic and Van der Waals allowing for prediction 
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of binding energies. Actual binding energies are extremely hard to calculate in-silico 
and the discrepancies with actual values can be large; however, this is still a good tool 
for estimation. The more negative the score, the tighter the binding of 
a ligand. Glyphosate had a docking score of -21.55 kJ/mol compared with E2 which 
had a docking score of -41.76 kJ/mol. Therefore, glyphosate might be able to bind to 
the LBC of ERa, but not as well as E2. A reason for glyphosate not binding as strongly 
might be because it is shorter in length compared to E2; therefore, it would be unlikely 
to form the same bonds at each end of the LBC as E2. Figure 3.14 shows that glyphosate 
is capable of forming some of the same hydrogen as E2 does with the LBC of ERa; 
hydrogen bonds with Glu353, and Arg394 through a water molecule. 
However, glyphosate is not capable of forming a hydrogen bond with His524 like E2 
does; this is located up to 8.67 Å and 9.90 Å away from atoms of glyphosate capable 
of forming these bonds. Hydrogen bonds have 3 categories, strong (2.2 - 2.5Å), 
moderate (2.5 - 3.2Å), and weak (3.2 - 4.4Å); thus, it is unlikely that hydrogen bonds 
would form between glyphosate and the key residues required for the binding of 
E2.258 However, this study used rigid docking which means that the ERa is locked in 
the conformation which is optimal for E2 because this was the original ligand bound in 
the crystal structure coordinates. It is possible in a protein dynamics simulation that the 
binding of glyphosate may improve because of the flexibility and mobility of proteins 
in their natural environment. Glyphosate’s binding to Glu353, and Arg394 through a 
water molecule might be enough to cause a conformational change which facilitates the 
dimerisation of the receptor leading to the translation and transcription of EREs. 
Protein dynamic modelling studies are the gold standard for in-silico investigations of 
the binding and interactions of ligands, however they require complex calculations 
carried by super computers. Rigid model docking is a good model for predicating 
whether a ligand has the potential to bind to ERa. Therefore, the risk of a compound in 
an estrogen mimic context can be predicted using Schrödinger software and the X-ray 
crystal structure coordinates of the human ERa. 
 
4.5 Risk Assessment for New Zealand Cow’s Milk  
 
This study extracted and identified the presence of xenoestrogens in New Zealand 
cow’s milk samples. However, the concentrations of the compounds found were low 
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and inconsistent; thus, they are probably irrelevant as risk factors to the associated 
effects of consuming estrogen mimics (e.g. increases risk of breast and prostate cancer, 
precautious puberty, decreased sperm count). It is likely that these compounds are part 
of a cocktail. These compounds have structural analogies; therefore, it is likely that they 
have additive effects on one another.  
 
4.5.1 The New Zealand Population’s Consumption of Cow’s Milk  
 
Cow’s milk is an important part of the western diet from birth, offering important 
vitamins, nutrients, fats, and other essential components.149 Cow’s milk is a dietary 
staple in the western diet and consumption in Asian countries is increasing as western 
diets become more ‘trendy’. For these reasons it would be expected that the daily 
consumption of liquid cow’s milk would be relatively high because it is used for coffee, 
tea, cooking, breakfast, and drinking on its own. The most recent data on the New 
Zealand populations milk consumption was recorded in 2013 by Food and Agriculture 
Organization of the United Nations.150 Here, it was reported that the amount of whole 
milk supplied per capita per day was 132.21 mL.150 The reason for selecting whole milk 
is because that this figure will not include other milk related products (e.g. cheese, 
butter). This figure also assumes that every single person in New Zealand drinks milk, 
which is highly unlikely. This is unlikely because of people’s allergies and diet choice 
meaning they do not drink cow’s milk.  Therefore, the real amount that a milk drinker 
in New Zealand will consume is likely to be slightly higher than 132.21 mL a day. 
However, this figure is for the amount of milk supplied per day per capita. New Zealand 
is the world’s leading dairy exporter; therefore, New Zealand is likely to supply more 
than what is consumed. For this reason, the assumption that the New Zealand 
population consumes 100% of what is supplied is unrealistic; but, for the purpose of 
carrying out a risk assessment of this study’s findings, the figure of 133 mL drunk per 
person per day will be used. This is because it is the most reliable and realistic amount 
that could be sourced; however, it is unlikely that large amounts of liquid milk are 
exported, dairy products are likely exported as solids.  
 
Something which should be considered is that milk is used in other products and not 
only consumed in liquid form. Some examples of these are in chocolate, biscuits, infant 
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formula, cheese, butter, whey protein, sour cream, cottage cheese, dips, custard, and ice 
cream.  Many people will consume at least one of these products daily, all of which use 
cow’s milk or milk solids to be produced. The presence of xenoestrogens have been 
previously reported in a range of dairy products, with the products highest in fat (cheese 
and yoghurt) containing the highest concentration of xenoestrogens.20, 207, 221, 228, 259-261 
Some of these products use milk solids rather than liquid milk to be produced (e.g. 
chocolate), and depending on the company and where the product is made will 
determine where the milk solids are sourced. It is possible that the milk solids used for 
the production of these products are sourced from other countries because they are 
cheaper to buy, or it is where the product is produced. In this case it is unknown what 
the cows were fed, how the milk is stored or treated, the regulations of the country 
where the milk solids were made, and how the final products are produced. These 
unknowns can have a large effect on the concentration of endogenous estrogens and 
xenoestrogens present; for example, these milk solids could be from hot humid 
climates. In these climates, pasture which cows are fed could be contaminated with 
Fusarium fungi and poorly stored. This is likely to lead to zearalenone contamination 
which could then contaminate the milk by the cow consuming these residues. This 
could also be present in the milk solid, and therefore, the products which these are 
included in. Thus, the dose of estrogen mimics could be higher in products which 
include dairy (e.g. chocolate) compared with liquid cow’s milk.  
 
4.5.2 Estrogenic Dose of New Zealand Cow’s Milk 
 
This study identified genistein, daidzein, and BPA in cow’s milk sample extracts. This 
is the first time that it has been published that these compounds have been identified in 
New Zealand cow’s milk. Below, a risk assessment for these compounds at their 
calculated concentrations will be carried out for a person who drinks the New Zealand 




One cow’s milk sample extract after the treatment of sulfatase/b-glucuronidase enzyme 
from H. pomatia was found to contain genistein at a concentration of 0.063 mg/L. This 
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would mean a dose of 8.246 x 10-3 mg would be received from drinking 133 mL of this 
milk. Genistein has a relative estrogenic potency (REP) of 0.03%, therefore the 
estrogenic dose received would be 2.47 x 10-4 mg if 100% of the dose was absorbed.151 
The ADI of genistein is 1.5 x 10-4 mg/kg bw, therefore for a 62 kg human, the dose is 
below the ADI, therefore if this person was to receive a dose of this concentration every 
day for the rest of their lives, no adverse effect would be expected to occur based on 
this ADI.205 It is possible that genistein is metabolised in the human gut by the 




A single cow’s milk sample extract was found to contain daidzein at a concentration of 
0.026 mg/L. This would mean a dose of 3.458 x 10-3 mg would be received if 133 mL 
of this cow’s milk was consumed. Daidzein has a REP of 1.0 x 10-4%, therefore the 
estrogenic dose received would be 1.33 x 10-5 mg if 100% of the dose was absorbed.151 
There is no available ADI for daidzein; however, it is expected that it would be similar 
to equol (ADI = 20; endpoint = death) or genistein (ADI = 1.5 x 10-4 ; endpoint = 
hormonal effect); therefore, for a 62 kg human the ADI would not be expected to be 
exceeded.205 Daidzein was only found in one sample. If the ADI set for daidzein was 
lower compared with equol and genistein, this could mean the ADI would be exceeded. 
However, it will still be expected that no effect would occur as this dose was only found 
in one milk sample. It should be considered that daidzein could be further metabolised 




BPA was found in 9 of 30 (30%) cow’s milk sample extracts at concentrations ranging 
from 0.012 mg/L to 0.066 mg/L. Therefore, the doses received would range from    
1.596 x 10-3 mg to 8.778 x 10-3 mg if someone drunk 133 mL of these cow’s milk. The 
REP of BPA is 5.1 x 10-3 %, therefore the estrogenic doses ranges from 8.14 x 10-6 mg 
to 4.477 x 10-5 mg. The ADI of BPA 0.05 mg/kg bw, therefore the dose calculated is 
unlikely to cause any adverse effects for a 63 kg human.206 It should be considered that 
in humans, BPA is rapidly absorbed from the gastrointestinal tract into blood.262 It is 
then conjugated with glucuronic acid in the liver through first pass metabolism, which 
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is then rapidly cleared from the body by elimination in the urine.262 Elimination usually 
occurs within 24 hours of oral doses.262 Therefore, it is highly unlikely that any adverse 




Glyphosate was not identified in 5 milk sample extracts analysed by direct injected 
probe mass spectrometry. The Ministry of Primary industries monitor milk for the 
presence of glyphosate, with published limit of reporting of 0.05 mg/L and limit of 
quantification of 0.01 mg/L.257 If milk contained glyphosate at a concentration of 0.01 
mg/L and 133 mL of milk was consumed, this person would receive a dose of 1.33 x 
10-3 mg per day if the dose was completely absorbed. This dose is over 100-fold smaller 
than glyphosate’s ADI of 0.5 mg/kg bw.263 However, if glyphosate has the ability to 
bind to the ERs, or cause changes to signaling or protein expression related to hormones 
synthesis (e.g. change the concentration of aromatase), the concentration of                  
1.33 x 10-3 received daily for a lifetime could lead to adverse effects.  
 
4.5.3 Worst Case Scenario of the Estrogenic Dose from New Zealand Cow’s 
Milk 
 
In this study genistein, daidzein, and BPA were identified in New Zealand cow’s milk 
sample extracts; however, the other target compounds (E2, EE2, formononetin, equol, 
zearalenone) may have still been present, but below their detection limits for this study. 
Therefore, a risk assessment should be carried out based on the compounds being 
present at the LOD because this is the lowest concentration which a compound is 
present, although it cannot be quantified. Shown in Table 4.1 is a summary of the worst-
case scenarios if the compounds of interest (E2, EE2, formononetin, genistein, daidzein, 
equol, BPA, zearalenone) for this study were found at their LOD. This was calculated 
using the New Zealand population’s average milk consumption per capita of 133 mL 
drunk daily. If the data presented in Table 4.3 was the real situation for every bottle of 
milk, there should be a huge concern. The reason for this is because the three most 
estrogenic target compounds of this study (E2, EE2) exceed their ADI for a 62 kg 
human. Although the ADI is the concentration at which a compound can be ingested 
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every day for a lifetime with no effect; if this is exceeded for an extended period of 
time, it is possible that adverse effects may occur. If this was the real situation it would 
be expected that milk would be investigated to reduce the concentration of compounds. 
If this situation was so bad, milk might be withdrawn for sale until the concentrations 
were reduced. It is highly unlikely that this is the case, and that the LOD for the method 
used in this study are too high to detect the actual concentrations (discussed in Section 
4.1.2).  
 
There is a large assumption with most risk assessments that the whole population 
consumes a product, and that it is consumed equally; however, this is highly unlikely 
to be the case. A proportion of the New Zealand population wont drink milk for health 
reasons (lactose intolerance) or by choice (personal preference, vegan, upbringing, 
diet), a portion of the population will also drink more milk (personal preference, 
nutritional value e.g. calcium).  Therefore, there is part of the population that will have 
no risk from cow’s milk, and there will be part of the population which might have a 
higher risk. When a risk assessment is carried out this should be considered, especially 
for compounds which are close to their ADI at the populations average consumption 
figure. It should also be considered that not everyone is the same weight. People that 
weigh less than the ‘average’ 62 kg will likely be of a higher risk because their dose/kg 





Table 4.3: Summary of worst case scenario of New Zealand cow’s milk if compounds 
were present at their LOD. The dose is calculated based on New Zealand 










E2 0.1 0.0133 100 0.0133 5 x 10-5  203 
EE2 0.05 6.65 x 10-3 91.15  151 6.061 x 10-3 4.3 x 10-5  204 
Formononetin 0.005 6.65 x 10-4 0.000205 264 1.363 x 10-7 N/A 
Genistein 0.005 6.65 x 10-4 0.03  151 1.995 x 10-5 1.5 x 10-4  205 
Daidzein 0.0025 3.325 x 10-4 0.0001  151 3.325 x 10-8 N/A 
Equol 0.01 1.33 x 10-3 0.07  151 9.31 x 10-5 20 
BPA 0.005 6.65 x 10-3 0.0051  151 3.312 x 10-6 0.05  206 
Zearalenone 0.025 3.192 x 10-3 0.63  151 2.011x 10-3 5 x 10-4  203 
 
4.5.4 Is New Zealand Cow’s Milk Safe? 
 
Genistein, daidzein and BPA were identified in New Zealand cow’s milk sample 
extracts. Genistein was found in one sample at a concentration of 0.063 mg/L, equating 
to an estrogenic dose of 2.47 x 10-4 mg. Daidzein was also found in one sample at a 
concentration of 0.026 mg/L, equating to an estrogenic dose of 1.33 x 10-5 mg. 
Whereas, BPA was found in 9 samples at concentrations ranging from 1.596 x 10-3 mg 
to 8.778 x 10-3 mg equating to estrogenic doses of from 8.14 x 10-6 mg to 4.477 x 10-5 
mg. At the doses that these compounds were found, none exceeded their ADI for a       
62 kg human. Based on the concentrations of the compounds found in this study, it is 
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expected that New Zealand cow’s milk is safe and poses no risk to the consumer in an 
estrogen mimic context for someone who consumes the population average of cow’s 
milk. As previously discussed, the whole population will not drink the same amount. 
Some of the population will drink more, and some will drink less based on preferences 
and health. This should be taken into consideration as some of the population will be 
receiving a higher does than expected, potentially putting them at a higher risk. It should 
also be considered that these compounds will be in a cocktail with one another. They 
have structural similarities and are likely to be estrogenic by a similar mechanism (i.e. 
binding to ERs); therefore, these compounds effects will likely be additive upon one 
another. This would therefore, increase the risk.  
 
A worst-case scenario should be considered for the compounds that were not found 
above their LOD in this study. The LOD for E2, EE2, equol, and zearalenone are high 
compared with concentrations which would be expected for them to be present at in 
cow’s milk. This is concerning because these (E2, EE2, equol, zearalenone) are the 
most estrogenic compound in their respective categories (endogenous estrogen, 
synthetic estrogen, phytoestrogen, mycotoxin respectively). If the compounds that were 
not found in this study were actually present at the method’s LOD, the risk assessment 
would be very different. E2 and EE2 would exceed their ADI for a 62 kg human. The 
risk assessment from this study would change to advising that cow’s milk should be 
highly monitored for E2 and EE2. If the concentrations of these compounds did not 
decrease below their ADI, milk may need to be withdrawn until the concentration of 
these compounds could be controlled. 
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 4.6 Conclusions and Future Work 
 
This study successfully used a method for extracting endogenous estrogens and 
xenoestrogens from cow’s milk to determine the levels of these compounds in New 
Zealand cow’s milk.  
 
The extraction method was chosen based on three factors: 
1. The compounds which were extracted  
2. The ease and quickness of the extraction procedure 
3. The reproducibility and quality of results 
 
 The recoveries of this method were varied being split into two groups; compounds 
which had low recoveries with BPA having the lowest (62%) and compounds which 
had high recoveries with EE2 having the highest (95%). The recoveries from this study 
are in line with previously published work that used other accepted methods for the 
extraction of endogenous estrogens and xenoestrogens from cow’s milk. 
 
The LOD and LOQ are important measures as they show the ability of the extraction 
and analytical methods. The LODs for the compounds of this study were varied with 
the lowest being daidzein (0.0025 mg/L) and the highest being E2 (0.1 mg/L). The 
LOQs followed a similar trend with formononetin, daidzein, equol, and zearalenone 
having the lowest (0.05 mg/L), and the highest being E2 (1 mg/L). The LODs for 
phytoestrogens were comparative with literature; however, for the endogenous 
estrogens, EE2, BPA and zearalenone the LODs were 1000 – 10,000-fold lower than 
reported in this study. 
 
In the analysis of New Zealand cow’s milk samples (n=30), BPA was found 9 times 
(30%), genistein once (3.3 %), and daidzein found once (3.3%). BPA was found at the 
lowest concentration of 0.012 mg/L and the highest concentration being 0.066 mg/L. 
The source of BPA is unlikely to be coming from the packaging because plastic milk 
bottles are made of food grade HDPE, and milk cartons are made of paperboard and a 
PE lining, none of which require BPA. However, some of the milking equipment, in 
particular the claw bowl, are made of plastic and the types of plastic used to make these 
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products could not be obtained due to a lack of response from a farming equipment 
supplier. Genistein was found at a concentration of 0.062 mg/L, and daidzein at a 
concentration of 0.026 mg/L. The likely source of these compounds is from the cow’s 
diet; however, it was a surprise that equol (a known phytoestrogen metabolite) was not 
present in milk too. The presence of glyphosate in New Zealand milk samples was also 
instigated following it being found in ice cream in the United Kingdom. A previously 
accepted extraction method was used to determine the presence of glyphosate, due to 
the low concentrations published, direct inject probe mass spectroscopy was used. In 
New Zealand cow’s milk samples (n = 5), no mass ion consistent with glyphosate was 
identified. 
 
One aspect of this study that was not conclusive was the source of BPA; is a well-
known endocrine disrupting chemical and the source of its presence in milk should be 
investigated. Efforts were made to contact companies to learn about their packaging 
and equipment, but no concise compounds or materials were provided by the equipment 
producer in particular. Therefore, future studies could further investigate the source of 
BPA by subjecting samples of plastics for infrared spectroscopy with appropriate 
sampling techniques. 
 
New Zealand cow’s milk appears safe for someone who consumes the New Zealand 
populations average amount of milk because BPA, genistein, and daidzein are below 
their ADI. It is possible that the ADI set was for an end point of an enzyme change (e.g. 
an upregulation of a liver enzyme) and not a hormonal change, which will be reflected 
in the ADI; therefore, it cannot be certain that there will no effect. However, these 
compounds are part of a cocktail. They are structurally similar having molecular 
similarities; therefore, it is possible that their effects are additive on one another. This 
could increase the risk of milk to the associated effects of consuming estrogen mimics. 
A worst-case scenario would be if the target compounds which were not found in this 
study (E2, EE2, formononetin, and zearalenone) were actually present at their LOD, 
this would set a new light on New Zealand cow’s milk safety as E2, and EE2 would 
exceed their ADIs. A similar scenario may be the case if someone drinks more than the 
population’s average consumption, or weighs less that the ‘average’, therefore 
regulators need to consider this when monitoring residues in milk.  
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This monitoring process of estrogenic compounds in milk should continue, and the 
method should be developed for LC-MS. Changing the analytical equipment should 
increase the sensitivity and therefore decrease the LOD and LOQ allowing for a more 
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